# agentsite-static-version=f7449b26-77cb-4634-9019-3858a95c67c1 # arisglobal.com > AI-optimized mirror of arisglobal.com containing 198 pages totalling 84,532 words of clean markdown content, structured data, and semantic HTML. Original source: https://arisglobal.com. Last updated: 2026-09-24T16:33:08.667Z. Each page is available as HTML (with JSON-LD structured data) and Markdown (text-only, ideal for LLMs and RAG). ## Homepage - [AI-Powered Life Sciences Software Platform | ArisGlobal LifeSphere](/content/site-root.html): Transform how life sciences teams operate with an AI-powered platform for drug development. Increase efficiency, ensure compliance, and scale with confidence. (349 words) ## Articles & Blog Posts - [企業としての市民活動 | ArisGlobal](/content/ja/corporate-citizenship/index.html): 健康な世界をめざして、探究とイノベーションを推進 ArisGlobalでは、ビジネスを超えて企業市民としての責任を果たすことを約束しています。これは、世界中の数百万もの人々の生活に有益な影響を及ぼすための道筋です。 コラボレーション (62 words) - [AI Pharmacovigilance Software for Drug Safety & Case Processing | ArisGlobal](/content/lifesphere/safety/index.html): Transform pharmacovigilance with AI-powered automation for case processing, signal detection, and compliance. LifeSphere Safety improves efficiency, quality, and global scalability., #products > div > div.fusion-layout-column.fusion_builder_column.fusion-builder-column-35.fusion_builder_column_1_3.\31 _3.fusion-flex-column{opacity:0!important;} (693 words) - [Customer login | ArisGlobal](/content/customer-login/index.html): Customers make all the difference. LifeSphere’s vibrant customer community is building tomorrow’s future. Our customer drives every decision we make. We value you, and we listen to your feedback and suggestions. As a customer, you have a dedicated Customer Success Manager to (365 words) - [Corporate Citizenship | ArisGlobal](/content/corporate-citizenship/index.html): Empowering Discovery and Innovation for a Healthier World  At ArisGlobal, our commitment to corporate citizenship extends beyond business it's our pathway to positively impact millions of lives worldwide. Collaborating with (458 words) - [breakthrough/index.html](/content/breakthrough/index.html) (262 words) - [The Value of Interconnected Data Across the Drug Development Lifecycle | ArisGlobal](/content/resources/the-value-of-interconnected-data-across-the-drug-development-lifecycle.html): Discover why an interconected data strategy can unleash potential within your organization and learn from experts why it's important to get started now with data governance., The management of data within organizations has far-reaching effects, as interconnected data provides valuable insights that can yield positive outcomes across various domains. However, drug development takes 8-15 years and incurs costs up to $11 billion. It relies on costly and often inefficient clinical trials, which lack insights into outcomes and side (1,334 words) - [Synergy and Efficiencies Within: The Benefits of a Connected Clinical Platform | ArisGlobal](/content/resources/synergy-and-efficiencies-within-the-benefits-of-a-connected-clinical-platform.html): Connected clinical platforms deliver a common user experience to maximize the potential of each solution for optimal performance and efficiency., Change is the lone constant you can depend on. When it comes to scientific discovery, most of that change – whether it be in smart phones or space travel – has led to greater achievements and efficiencies. Among Clinical trials, however, efficiency continues to be a challenge. Clinical development success rates have fallen (1,472 words) - [Find Out How to Select an eTMF & eTMF Vendor | ArisGlobal](/content/resources/how-to-select-the-right-etmf-system-and-vendor/index.html): See what should you consider when selecting an eTMF vendor for your clinical trial master file needs & find common mistakes to avoid during vendor selection., Managing your Trial Master File (TMF) is a necessary, and often tedious task for most clinical stakeholders—but it doesn’t have to be. When teams rely on legacy systems using outdated file sharing technology or homegrown systems leveraging spreadsheets or paper, they open themselves up to vulnerabilities in managing sensitive trial data and essential documents. (1,295 words) - [Regulatory Revolution: Unlocking the Era of Connected Insights | ArisGlobal](/content/resources/regulatory-revolution-unlocking-the-era-of-connected-insights.html): What's the future of regulatory? What will it take to level up? Learn what the future holds as it transforms this aspect of life sciences., Nothing evolves within a vacuum. While today we can transmit reports, research, and more at the click of a button, this was science fiction fifty years ago. In parallel, regulatory information management was a vague concept with paper submissions being physically transported to reviewers. Regulations were national and required the review of a (1,820 words) - [wp-content/uploads/2024/09/posh-policy-20231-pdf.html](/content/wp-content/uploads/2024/09/posh-policy-20231-pdf.html) (3,254 words) - [Transforming Medical Affairs Engagement with Generative AI | ArisGlobal](/content/resources/transforming-medical-affairs-engagement-with-generative-ai.html): In today's rapidly evolving landscape of medical affairs, stakeholder engagement extends beyond key opinion leaders to include community physicians, payers, and other value-based decision-makers. Generative AI (GenAI) is at the forefront of this transformation, offering personalized and scalable engagement strategies. Let's explore how medical affairs can leverage these innovations to enhance engagement drive transformative outcomes.The (1,016 words) - [Top Reasons to Attend Breakthrough2024 | ArisGlobal](/content/resources/top-reasons-to-attend-breakthrough2024/index.html): ArisGlobal’s annual Breakthrough is a one-of-a-kind event bringing together industry leaders, regulatory authorities, the ArisGlobal customer community, and academia to learn about what’s next in life sciences!, ArisGlobal’s annual Breakthrough is a one-of-a-kind event bringing together industry leaders, regulatory authorities, the ArisGlobal customer community, and academia to learn about and share what’s next in life sciences!With a clear focus on the next phase of innovation, leaders from around the world are going to share how they’re leveraging the latest evolution in (709 words) - [Top 5 Reasons LifeSphere CTMS Works for CROs | ArisGlobal](/content/resources/top-5-reasons-why-lifesphere-clinical-trial-management-system-works-for-cros.html): With ArisGlobal’s LifeSphere Clinical Trial Management System (CTMS), as CROs you can meet study timelines and reduce stress in a single unified platform., Working in clinical operations at a small or midsized Clinical Research Organization (CRO), you fully understand the complexity of drug research. What’s extra frustrating is the headache of managing an array of paper and spreadsheets, homegrown or legacy systems. But there is a better way. With ArisGlobal’s LifeSphere (817 words) - [Connected Data, Interoperability Enable Greater Compliance and Beyond | ArisGlobal](/content/resources/connected-data-interoperability-enable-greater-compliance-and-beyond.html): Because Regulatory teams play a role in every phase of development, it’s every domain that benefits when these teams gain greater insight through shared data., Regulatory teams serve as the common thread of pharmaceutical research and development, connecting each domain on a drug’s journey to approval. Theirs is the only function that plays a role in every stage of bringing a drug to market, from initial research through trial, to regulatory approval, and even in post-marketing pharmacovigilance. It would be reasonable to assume, then, that these teams (957 words) - [LifeSphere Electronic Trial Master File (eTMF) System Extends Clinical Collaboration | ArisGlobal](/content/resources/lifesphere-electronic-trial-master-file-etmf-system-extends-clinical-collaboration.html): ArisGlobal is forging a new path. ArisGlobal’s LifeSphere eTMF system is enhancing collaboration at the center of the clinical research enterprise., Collaboration is at the heart of most medical breakthroughs. But too often, outdated clinical information management can make working relationships difficult. For instance, clinical research sites struggle when made to force fit proprietary solutions to meet partner needs. In fact, (516 words) - [Breakthrough 2020: The biggest takeaways from ArisGlobal’s virtual event | ArisGlobal](/content/resources/breakthrough-2020-the-biggest-takeaways-from-arisglobals-virtual-event.html): On October 28 and 29, Breakthrough 2020, ArisGlobal’s virtual technology summit, brought together members of the life sciences community for two days of discussions on technology, innovations and trends powering the next generation of life sciences.In a time where so much is uncertain, the event allowed industry professionals to come (1,016 words) - [Setting a New Standard in Safety Signal Analytics | ArisGlobal](/content/resources/setting-a-new-standard-in-safety-signal-analytics/index.html): Discover the new frontier in safety signal analytics with LifeSphere Clarity and unlock new insights within your safety data., ArisGlobal Announces the Launch of LifeSphere Clarity As a pharmacovigilance professional working in life sciences today, you know that the safety signal (725 words) - [Regulatory Structured Authoring: Next Steps in Achieving Greater Efficiencies and Consistency | ArisGlobal](/content/resources/regulatory-structured-authoring-next-steps-in-achieving-greater-efficiencies-and-consistency.html): Moving to a structured content authoring approach presents the challenge of ensuring that data and documents are in sync. So where do life sciences organizations stand today in this transformation phase? Wim Cypers, Senior VP, Regulatory, shares his insights from our recent webinar., An excerpt from the ArisGlobal white paper “Regulatory 2025: Developing an Effective 10-year Strategy for Technology-Enabled Regulatory Transformation,” shares how the increasing regulatory agency demand for quality metrics in data submissions is driving the need for structured data:“The emphasis that regulatory authorities place on quality systems creates important considerations for (698 words) - [Search for Simplicity, Scalability and Timely Insights in Regulatory Affairs | ArisGlobal](/content/resources/the-search-for-simplicity-scalability-and-timely-insights-in-regulatory-affairs.html): Search for simplicity, scalability & timely insights in Regulatory Affairs and how cloud-based RIMS can simply manage solutions.Read the Blog, Rising Expectations from Regulatory Affairs ExecutivesAs we all know from experience, not all cloud solutions are the same and cloud-based regulatory information management (RIMS) has to go further than simply managing solutions if it’s going to bring break-through change to regulatory affairs.Take for example the way all employees, globally, use the system. A simple user (607 words) - [Building an Open, Interconnected Regulatory Data Ecosystem | ArisGlobal](/content/resources/building-an-open-interconnected-regulatory-data-ecosystem.html): Most regulatory information management (RIM) systems were designed to capture essential regulatory data elements, e.g., drug substance and drug product metadata, and to build compliant submissions, while recognizing the importance of connecting to publishing, document management and registration management as part of an end-to-end platform (E2E), with connected workflows, triggers, and notifications. However, with (1,258 words) - [How Regulatory Information Management Simplifies Requirements for Medical Devices | ArisGlobal](/content/resources/simplify-requirements-for-medical-devices-with-regulatory-information-management-systems.html): Keeping track of information required to manage your medical devices on the market is a complex task. Learn more about regulatory information management software with ArisGlobal., Keeping track of all the information required to manage your medical devices on the market is a hugely complex task, and is becoming progressively more difficult. Growth in your product portfolio means a higher volume of data to manage, tighter regulatory requirements create stricter timelines and oversight for products on the market, and more stringent (726 words) - [The Path to Breakthrough | ArisGlobal](/content/resources/the-path-to-breakthrough/index.html): Learn why Breakthrough is more than just an event but a summit for thought leaders in health and life sciences to discuss today and the future., ​We live for breakthroughs. Every day, health and life sciences organizations are leading discoveries and engineering the future, driving an aspiration to make the world a better place. This is why we are here — we help enable the path that makes breakthroughs possible. We created Breakthrough2021, a virtual event bringing together key members of the life sciences and digital health community to provide insights into innovation, technology including automation, AI (artificial intelligence), and digital transformation to impact and shape the future of global (665 words) - [Is Regulatory Affairs Ready for Automation - Rating Your Organization’s Regulatory Data Science Capabilities | ArisGlobal](/content/resources/is-regulatory-affairs-ready-for-automation-part-3-rating-your-organizations-regulatory-data-science-capabilities.html): The regulatory landscape is slowly but surely evolving with increasing telematics demands driven in Europe. There is a clear move away from a traditional document focus to data management. Regulatory Analytics & Informatics and automation has potential to embrace regulatory changes. Read the blog, On December 6th, 2017, ArisGlobal held a webinar with DIA, “Is Regulatory Affairs Ready for Automation?” In this webinar, our presenter, David Scanlon, Senior Director of Regulatory Strategy, posed three related polling questions to the audience, and their responses to each came up with some interesting information, as shared in the Part 1 (621 words) - [Regulatory Affairs Should Respond to Strategic Business Drivers | ArisGlobal](/content/resources/think-big-regulatory-affairs-must-prepare-to-respond-to-strategic-business-drivers.html): ArisGlobal expert shares how life science organizations should prepare for 2020 regulatory affairs RIMS technology landscape. Read the Blog, Regulatory affairs departments are accustomed – and even open -- to change and adapting their technology and processes in response to compliance and business pressures. Typically, regulatory affairs leaders respond to such drivers as “how do we improve efficiency?,” “how do we speed the process to improve time to market?,” and “what do we need (418 words) - [5 Reasons to Move to Automated Safety Document Distribution | ArisGlobal](/content/resources/5-reasons-to-move-to-automated-safety-document-distribution.html): The very basis of pharmacovigilance is to detect, collect, monitor, and assess reports on adverse events from drug and biologic products. These reports can range in severity but all aim to support one thing – human safety. The distribution of safety event reports to investigator sites, ethics committees, and Institutional Review Boards (IRBs) (1,312 words) - [How RIMS Help Manage Increasing Complexity in Regulatory Affairs | ArisGlobal](/content/resources/how-rims-help-manage-increasing-complexity-in-regulatory-affairs.html): See how a 360 approach in Regulatory Information Management Systems creates efficiency/accuracy throughout the Regulatory Affairs lifecycle., Managing the submission of medicinal products, medical devices, and biologics to regulatory agencies is growing more complicated all the time. To streamline the processes that go into creating and tracking these submissions, life science organizations are increasingly relying on Regulatory Information Management Systems, or RIMS.  What is a RIMS (Regulatory Information Management System)? (1,466 words) - [Removing the Squeeze on Clinical Operations | ArisGlobal](/content/resources/removing-the-squeeze-on-clinical-operations-through-transparency-integration-and-automation.html): LifeSphere Clinical adopts a TCO approach tackling the multiple challenges that clinical operations departments and CROs face. Read the Blog, From reporting challenges to data integration and data silos with clinical data management, to the continuing search for greater automation, clinical operations and contract research organizations (CROs) face mounting challenges. The squeeze on the bottom line means they must do all of this – and more – with fewer (506 words) - [Regulatory process transformation – including closer collaboration with Safety/PV - starts with cloud-based RIM | ArisGlobal](/content/resources/regulatory-process-transformation-including-closer-collaboration-with-safety-pv-starts-with-cloud-based-rim.html): Today, more than 15 health agencies globally are using ArisGlobal LifeSphere solutions to streamline a range of processes., At Breakthrough 2024 this month, Hans van Leeuwen, Head of RA Data and Systems Excellence at Astellas Pharma, will deliver a keynote on the company’s journey to the cloud for regulatory information management. As well as enabling data-driven Regulatory processes, the transition is part of a strategic move to make RA the original source for Safety (550 words) - [Balancing Speed, Safety, and Risks in a Global Pandemic | ArisGlobal](/content/resources/balancing-speed-safety-and-risks-in-a-global-pandemic.html): In the age of Covid-19, the cause of a global pandemic, everything has changed over the last year in nearly every aspect of life. The pharmaceutical industry is at the center of this on helping to mitigate. We have seen dramatic adjustments in the way vaccines are developed, tested, and surveilled (584 words) - [Transforming Life Sciences Agility on Both Sides of the Regulatory/Safety Sphere: A Year of Health Authority Successes | ArisGlobal](/content/resources/transforming-life-sciences-agility-on-both-sides-of-the-regulatory-safety-sphere-a-year-of-health-authority-successes.html): Today, more than 15 health agencies globally are using ArisGlobal LifeSphere solutions to streamline a range of processes., Today, more than 15 health agencies globally are using ArisGlobal LifeSphere solutions to streamline a range of pharmacovigilance and regulatory processes, all to the benefit of patients.Following a very busy year, we’re thrilled to report (441 words) - [DIA 2018 Annual Conference - Transforming Life Sciences Productivity](/content/resources/a-month-following-dia-2018-annual-meeting-how-transforming-life-sciences-productivity-through-cognitive-platforms-is-driving-insights-to-action.html): The DIA Annual conference represented a perfect fit for where ArisGlobal LifeSphere® technology is innovating and evolving to strengthen and streamline., “Driving insights to action” was this year’s DIA Annual conference theme, and represented a perfect fit for where ArisGlobal LifeSphere® technology is innovating and evolving to strengthen and streamline product lifecycle management for good clinical practice and good regulatory practice. In two interconnected sessions, ArisGlobal’s subject matter experts presented “How Cognitive E2E Pharma Platforms Can (652 words) - [5 New Innovations Set to Transform Regulatory Information Management | ArisGlobal](/content/resources/5-new-innovations-set-to-transform-regulatory-information-management.html): What's the future of regulatory? What will it take to level up? Learn what the future holds as it transforms this aspect of life sciences., Learn how exciting new technological innovations are set to impact how regulatory information management teams work in 2024 and beyond.The Rise of Artificial Intelligence in Life (888 words) - [The Clinical Domain is Evolving. Make Sure your CTMS is Evolving with It. | ArisGlobal](/content/resources/the-clinical-domain-is-evolving-make-sure-your-ctms-is-evolving-with-it.html): ArisGlobal hosted a webinar titled “The Evolving Role of CTMS in Risk Management” discussing the challenges facing modern clinical trial management., In April 2020, ArisGlobal hosted a webinar titled “The Evolving Role of CTMS in Risk Management”. During the webinar, Sondra Pepe, Senior Director, Clinical Business Unit, discussed the challenges facing modern clinical trial management, and how clinical trial managers can position themselves (351 words) - [The Concept of Smart ICSRs | ArisGlobal](/content/resources/experience-expertise-and-understanding-building-critical-insight-into-smart-icsrs.html): Individual Case Safety Reports, or ICSRs, are a large part of the safety and pharmacovigilance lifecycle. From reporting product problems, adverse events, and consumer complaints, the information they provide is integral in ensuring the safety of medicinal products., Individual Case Safety Reports, or ICSRs, are a large part of the safety and pharmacovigilance lifecycle. From reporting product problems, adverse events, and consumer complaints, the information they provide is integral in ensuring the safety of medicinal products. Traditionally, ICSRs were seen as cumbersome, though widely accepted that ICSRs are a necessary tool. Today, organizations can handle (431 words) - [Revolutionizing Data: The Power of Advanced Intake | ArisGlobal](/content/resources/revolutionizing-data-the-power-of-advanced-intake/index.html): In the ever-evolving landscape of data management, the life sciences and pharmaceutical industry faces unique challenges. Patient data, often sensitive and complex, demands efficient processing. With the advent of groundbreaking technologies like Generative AI (GenAI) and Large Language Models (LLMs), the industry now has the opportunity to disrupt traditional data intake approaches and transform them (496 words) - [ArisGlobal expert shares how Regulatory Affairs needs to adapt change | ArisGlobal](/content/resources/arisglobal-expert-shares-how-regulatory-affairs-needs-to-adapt-to-transformation-change.html): ArisGlobal expert shares how Regulatory Affairs needs to adapt to transformational change for life sciences companies to succeed. Read the Blog, The life sciences industry is confronting a wave of transformational change, brought about by multiple factors, including the growth of new clinical trial markets, a rapid rise in drug development innovation, reimbursement challenges, heightened regulatory requirements and a demand for evidence-based medicine, among many others. These drivers and the resultant changes are having a profound (507 words) - [Regulatory Information Management: Solving the Compliance Challenge | ArisGlobal](/content/resources/regulatory-information-management-solving-the-compliance-challenge-with-a-new-approach.html): A preview of DIA’s upcoming Regulatory Conference, where ArisGlobal will unveil its revolutionary regulatory information management system software. Read the Blog, A preview of DIA’s upcoming Regulatory Conference, where ArisGlobal will unveil its revolutionary regulatory information management system software.It’s no secret, the main role of any pharmaceutical company’s regulatory affairs (RA) department is to interact with the regulators of different countries throughout the development, registration and marketing phase of the product life cycle – all with the goal (491 words) - [3 Changes (and Benefits) of the EU Clinical Trials Regulation | ArisGlobal](/content/resources/3-changes-and-benefits-of-the-eu-clinical-trials-regulation.html): What's next for clinical trials in the European Union? Learn what the new EU Clinical Trial Regulation changes for organizations., The European Union (EU) Clinical Trials Regulation (CTR) harmonizes the processes for assessment and supervision of clinical trials throughout the EU. Effective from January 2022, it means to foster innovation and research in the region.Prior to the CTR, clinical trial sponsors had to submit clinical trial applications separately to national competent authorities and ethics committees in each country to gain regulatory approval (734 words) - [Breaking Silos across Life Sciences helps drive Innovation | ArisGlobal](/content/resources/breaking-down-silos-across-the-life-sciences-enterprise-helps-drive-innovation.html): As Life Sciences companies look to bring innovative new drugs to market, they are seeking ways to resolve long-standing issues. Read our blog, Silos have long plagued the life sciences industry, and nowhere is this more notable than with how information and data are shared across the product life cycle.As life sciences companies look to bring innovative new drugs to market, they are seeking progressive ways to resolve long-standing issues that hinder regulatory compliance, productivity and total cost (518 words) - [Newscast - LifeSphere Mobile MA Self Service Medical Information Portal](/content/resources/newscast-lifesphere-mobile-ma-self-service-medical-information-portal-for-medical-affairs-and-pharmacovigilance.html): ArisGlobal announces LifeSphere Mobile MA, a complete self service medical information portal for Medical Affairs and PV. Watch the Newscast, LifeSphere® Mobile MA is the first multi-lingual, self-service medical information portal and mobile app to help sales reps, medical science liaisons, healthcare professionals and even patients access approved product content, report potential adverse events (AEs), and submit medical inquiries and product quality complaints from any mobile device. Medical information management (216 words) - [7 Things to Consider When Moving to an eTMF (Electronic Trial Master File) System | ArisGlobal](/content/resources/7-things-to-consider-when-moving-to-an-etmf-electronic-trial-master-file-system.html): Considering transitioning from a paper trial master file to an electronic one? Here are 7 tips to help select the right eTMF the first time., Considering switching from a paper trial master file to an electronic one? There’s no better time than now.According to the 2022 TMF Reference Model Survey, 34% of organizations use a combination of paper and eTMF, and 49% retain all or some paper. Paper trial master files can be costly, time-consuming, and error-prone. If (639 words) - [Digitization Changing the Regulatory Affairs Role | ArisGlobal](/content/resources/arisglobal-viewpoint-how-digitization-changes-the-role-of-regulatory-affairs.html): The positive digital disruptions taking place within Regulatory Affairs will impact how we work, collaborate and share in Life Sciences and healthcare industries. Read the Blog, This is the last in the ArisGlobal three-part blog series on Regulatory Affairs transformation. Digitization is sweeping the life sciences industry, disrupting traditional working (543 words) - [A Secret Weapon to Act on your IDMP Assessment | ArisGlobal](/content/resources/a-secret-weapon-to-act-on-your-idmp-assessment/index.html): What does It mean to use technology solutions to solve your IDMP assessment? Read this ArisGlobal blog to learn how to leverage this “secret weapon.”, If you’re in Regulatory Affairs, you know the IDMP-compliance-truck is headed your way. Which questions though are plaguing your team? Wondering how to work on the recommendations from an initial IDMP Readiness Assessment? Still evaluating if an initial IDMP-readiness assessment will give you concrete visibility on how you will tackle the (664 words) - [Homepage Animation | ArisGlobal](/content/homepage-animation/index.html): ArisGlobal Launches LifeSphere NavaX™ The Next Generation Cognitive Computing Engine to Expedite R&D Digitization for Life Sciences LifeSphere NavaX is your gateway to a future where advanced automation, AI, and intelligent data analytics converge to revolutionize your business and drive better end-to-end outcomes. GenAI In Safety Regulatory (174 words) - [ArisGlobal Hosts Webinar Focusing on Regulatory Affairs Transformation Drivers for SMP Organizations | ArisGlobal](/content/resources/arisglobal-hosts-webinar-focusing-on-regulatory-affairs-transformation-drivers-for-smp-organizations.html): ArisGlobal hosted a webinar titled Regulatory Affairs Transformation Drivers for Small and Medium Life Sciences Companies. The webinar examines the main factors to consider when addressing digital maturity., On May 14, 2020, ArisGlobal hosted a webinar titled Regulatory Affairs Transformation Drivers for Small and Medium Life Sciences Companies, hosted by Pratyusha Pallavi, Senior Director of Regulatory and Quality at ArisGlobal.In this webinar, Pratyusha discussed how Regulatory Affairs in small and medium-sized pharmaceutical organizations (SMP) have a unique (486 words) - [5 Reasons to Attend Breakthrough This Year | ArisGlobal](/content/resources/5-reasons-to-attend-breakthrough-this-year/index.html): There are many reasons to attend ArisGlobal's Breakthrough conference, but here are five of our top benefits attendees will experience., ArisGlobal’s annual Breakthrough event is a one-of-a-kind event bringing together key leaders of the life sciences and digital health community. This year’s event will highlight leading voices from across the industry sharing ideas, experiences, and best practices May 24-25 in Chicago, IL. Here are five reasons you should attend Breakthrough. (482 words) - [LifeSphere Regulatory Platform Brings Game-Changing Efficiency to Life Sciences | ArisGlobal](/content/resources/arisglobals-lifesphere-regulatory-platform-brings-game-changing-efficiency-to-life-sciences.html): ArisGlobal's all-new cloud platform LifeSphere Regulatory provides full end-to-end regulatory information management within an easy and unified suite, If you are on the front lines of regulatory information management within the life sciences industry, you know how important it is to keep organized, move fast, streamline internal collaboration, and prepare for the future. Regulatory affairs is an essential part of the drug development process, as it ensures organization-wide compliance with all (327 words) - [LifeSphere CTMS10 Brings Full Visibility to Clinical Trials | ArisGlobal](/content/resources/arisglobals-lifesphere-ctms10-brings-complete-control-and-full-visibility-to-clinical-trials.html): ArisGlobal's LifeSphere CTMS, a versatile clinical trial management cloud solution, delivers end-to-end clinical trial management in a single application., It’s important to achieve and maintain complete control over the clinical trial process. There is no better way to obtain this than with the newly updated LifeSphere® CTMS10. This clinical product has undergone various changes and improvements throughout the past year in preparation for this release.A versatile Clinical Trial Management Solution, LifeSphere CTMS10 maintains the (358 words) - [ArisGlobal to Present at the Global Regulatory Affairs Summit Digital Week | ArisGlobal](/content/resources/arisglobal-to-present-at-the-global-regulatory-affairs-summit-digital-week.html): At the Global Pharmaceutical Regulatory Affairs Summit Digital Week, ArisGlobal's Christina Johnston will be presenting “AI Enhanced RIMS: What the Future Holds”., At the Global Pharmaceutical Regulatory Affairs Summit Digital Week, on June 25th, 2020, Christina Johnston, Associate Director Product Management Regulatory at ArisGlobal will be presenting “AI Enhanced RIMS: What the Future Holds”.Throughout the different verticals within life sciences, the uptake of AI software solutions has been growing at different rates.  Regulatory Affairs and their solution (281 words) - [fusion_tb_category/header/index.html](/content/fusion_tb_category/header/index.html) (443 words) - [Realizing the importance of emerging CROs | ArisGlobal](/content/resources/a-level-playing-field-realizing-the-importance-of-emerging-cros.html): ArisGlobal’s Agile CRO program is a healthy technological proposition for emerging CROs to drive end-to-end clinical processes. Red our Blog, With declining R&D budgets, increased competition from larger CROs and patent expirations, emerging CROs have evolved from being non-core service providers to being integral partners in the earliest to the latest stages of the drug discovery and development process. According to a Grand View Research report, the global healthcare CRO market is expected to reach (351 words) - [AI Enhanced RIMS: What the Future Holds for Regulatory](/content/resources/ai-enhanced-rims-what-the-future-holds-for-regulatory.html): Find out how your regulatory team can benefit from AI enhanced RIMS solution with speed, quality, & collaboration delivered in one simple unified platform., Christina Johnston, Associate Director of Product Management for Regulatory at ArisGlobal, recently presented “AI Enhanced RIMS: What the Future Holds” as part of the Global Pharmaceutical Regulatory Affairs Summit Digital Week.During the presentation, Christina explored some barriers to implementing (305 words) - [NewsCast: Industry's only E2B R3 Safety Platform Multi-Tenant Cloud Platform | ArisGlobal](/content/resources/arisglobal-newscast-industrys-only-e2b-r3-compliant-safety-multi-tenant-cloud-platform.html): LifeSphere Safety MultiVigilance is the only E2B R3 compliant multi-tenant cloud solution in the safety market. Watch the Newscast!, LifeSphere® Safety MultiVigilance is the only E2B R3 compliant multi-tenant cloud solution in the safety market. Customers already using this software are benefiting from the automation capabilities and experiencing up to 30% productivity gains in data entry & case processing. Watch this interview with Vivek Ahuja, VP Pharmacovigilance, ArisGlobal, to learn (187 words) - [fusion_tb_category/footer/index.html](/content/fusion_tb_category/footer/index.html) (341 words) - [fusion_tb_category/content/index.html](/content/fusion_tb_category/content/index.html) (378 words) - [Our Customers | ArisGlobal](/content/our-customers/index.html): Your Content Goes Here Learn More (96 words) - [Resources and Support | ArisGlobal](/content/resources-2-2/index.html) (92 words) - [Search Results | ArisGlobal](/content/search-results/index.html) (90 words) - [Test Center | ArisGlobal](/content/test-center/index.html): Yo! (92 words) - [A Look Back at Partnerships in Clinical Trials Europe | ArisGlobal](/content/resources/a-look-back-at-partnerships-in-clinical-trials-europe.html): A recap of the 2016 Partnerships in Clinical Trials Europe conference and the unique challenges faced by CROs. Read the Blog to learn more., By Danilo PavlovicAs both a conference attendee and ArisGlobal representative in our booth on the show floor at the recent Partnerships in Clinical Trials Europe, I had plenty of opportunity to sit in on sessions, talk to industry colleagues and meet with attendees. From show-floor chat (528 words) - [Testimonials | ArisGlobal](/content/testimonials/index.html): Incorporating AI into my website was the best decision. It has fully streamlined my processes, improved customer interactions, and the results are reflecting in my sales. My website is not just a platform; it's a dynamic business partner. It anticipates my needs and provides solutions before I even realize I (252 words) - [LifeSphere Suite | ArisGlobal](/content/lifesphere-suite/index.html) (91 words) - [Submission Management Application | LifeSphere Publishing | ArisGlobal](/content/lifesphere/regulatory-submission-publishing/index.html): LifeSphere Publishing software is a simple and robust regulatory submission publishing application that allows teams to easily compile, publish, & validate., This is an example page. It's different from a blog post because it will stay in one place and will show up in your site navigation (in most themes). Most people start with an About page that introduces them to potential site visitors. It might say something like this: (221 words) - [Right-sized RIMS: Discover a Purpose-Built Solution for Investigational-Stage Companies | ArisGlobal](/content/right-sized-rims-discover-a-purpose-built-solution-for-investigational-stage-companies.html): Time and funding to support growth are precious resources to investigational-stage life sciences companies. When success is measured by the next positive study result or regulatory milestone successfully met, you cannot afford to squander it either. (99 words) - [LifeSphere Product Complaints Management System | ArisGlobal](/content/lifesphere/medical-affairs/product-complaints/index.html): LifeSphere Complaints is a complete complaint management system that is designed to log & track complaints & provide effective resolutions to customer issues., This is an example page. It's different from a blog post because it will stay in one place and will show up in your site navigation (in most themes). Most people start with an About page that introduces them to potential site visitors. It might say something like this: (274 words) - [White Paper: Unleashing AI in PV | ArisGlobal](/content/white-paper-unleashing-ai-in-pv/index.html): Artificial intelligence and machine learning offer key opportunities for pharmacovigilance professionals, but they require models that are trained and validated to provide quality results. (97 words) - [White Paper: Touchless Case Processing – A PV Advantage White Paper | ArisGlobal](/content/white-paper-touchless-case-processing-a-pv-advantage-white-paper.html): Check out our whitepaper to learn what touchless case processing is and how safety teams are utilizing it to process cases faster and without manual intervention. (102 words) - [Resources | ArisGlobal](/content/resources-old/index.html) (90 words) - [Unlock the Full Potential of Your Safety Data | ArisGlobal](/content/unlock-the-full-potential-of-your-safety-data/index.html): With LifeSphere, pharmacovigilance teams can harness the industry’s most advanced end-to-end safety signal detection and analytics engine. (99 words) - [Seamless Integration: Unlock Real-Time Access to Your Safety Data | ArisGlobal](/content/seamless-integration-unlock-real-time-access-to-your-safety-data.html): With LifeSphere, pharmacovigilance teams can harness the industry’s most advanced end-to-end safety signal detection and analytics engine. (100 words) - [Unlocking the Strategic Value of Pharmacovigilance | ArisGlobal](/content/strategic-value-of-pharmacovigilance/index.html): Transform safety into a value driver through advancements in technology, automation, and data and analytics. Download the whitepaper. (96 words) - [LifeSphere Signal and Risk Management + LifeSphere Clarity | ArisGlobal](/content/identifyriskfaster/index.html): With LifeSphere, pharmacovigilance teams can harness the industry’s most advanced end-to-end safety signal detection and analytics engine. (103 words) - [Safety Signal Checklist | ArisGlobal](/content/safety-signal-checklist/index.html): With LifeSphere, pharmacovigilance teams can harness the industry’s most advanced end-to-end safety signal detection and analytics engine. (94 words) - [LifeSphere | Customer Community | ArisGlobal](/content/customer-resources/index.html): Customers make all the difference. LifeSphere’s vibrant customer community is building tomorrow’s future. Our customer drives every decision we make. (91 words) - [LifeSphere Innovation | Collaborative Innovation in Life Sciences](/content/innovation/index.html): Collaborative innovation drives life sciences forward, together. From the beginning, we built LifeSphere hand-in-hand with leading life sciences organizations. (92 words) - [NavaX | ArisGlobal](/content/ja/navax/index.html): Meet NavaX The AI Engine Purpose-built for Life Sciences NavaX is your gateway to a future where advanced automation, AI, and intelligent data analytics converge to revolutionize your business and drive better end-to-end outcomes.From Robotic Process Automation, Machine Learning, and Natural Language Processing to Large Language Models, Generative AI, and now Agentic (127 words) - [Who You Are | ArisGlobal](/content/who-you-are/index.html): LifeSphere was designed to help you do more, faster and safer than ever before. (92 words) - [Services | LifeSphere](/content/services/index.html): LifeSphere’s platform simplifies core processes of research and development. (90 words) - [resources/index.html](/content/resources/index.html) (496 words) - [Partners | ArisGlobal](/content/partners/index.html): Discover ArisGlobal's ecosystem of partners, created to best serve our customers across the life sciences R&D lifecycle., An ecosystem of proven partners to enable customer success Supercharge your patient treatment initiatives by collaborating with one of ArisGlobal’s strategic partners Become a Partner An ecosystem of proven partners to enable customer success (217 words) - [Leadership | ArisGlobal](/content/leadership/index.html): $(document).ready(function() { // Desired offset in pixels var offset = 120; // Adjust this to the amount you need (120px in your case) // Function to adjust the scroll position function adjustScrollPosition(targetElement) { // Check if the target element exists if (targetElement.length) { (1,270 words) - [Blog | ArisGlobal](/content/blog/index.html) (278 words) - [Lifesphere Modular | ArisGlobal](/content/lifesphere-modular-solutions/index.html): Solutions Resources Let's Talk Unlock PV Innovation withGenAI-Powered Modular Solutions Cutting-Edge capabilities. Seamless integration. Limitless potential.​ Download Checklist Download the Modular Checklist Register for the Modular Webinar, (512 words) - [Ungated Archives | ArisGlobal](/content/gate/ungated/index.html) (264 words) - [gated Archives | ArisGlobal](/content/gate/gated/index.html) (342 words) - [Privacy Policy | ArisGlobal](/content/privacy-policy/index.html): Privacy Policy Thank you for reviewing the ArisGlobal Privacy. The ArisGlobal Company and its family of companies (“ArisGlobal”) are sensitive to the issue of confidentiality in online interactions (1,030 words) - [Intelligence Agents: Unlock AIntelligence Agents: Unlock Autonomous Regulatory Compliance | ArisGlobal](/content/intelligence-agents/index.html): Intelligence Agents: Unlock Autonomous Regulatory Compliance Ensure simple, efficient, and consistent compliance with the latest regulatory requirements using autonomous agentic workflows and decision intelligence. Let's Talk View Brochure Agentic AI-Powered Regulatory Compliance and Decision Support Intelligence Agents, powered by NavaX, enables smarter regulatory (475 words) - [Drug Safety Analytics for Life Sciences | LifeSphere Data and Analytics](/content/lifesphere/data-analytics/index.html): LifeSphere Data and Analytics enables safety teams to drive higher-quality benefit-risk analyses and greater patient safety. , #products > div > div.fusion-layout-column.fusion_builder_column.fusion-builder-column-28.fusion_builder_column_1_3.\31 _3.fusion-flex-column{opacity:0!important;} (333 words) - [Discover How GenAI Has Changed Regulatory Affairs | ArisGlobal](/content/genai-in-regulatory/index.html): Discover How GenAI Has Changed Regulatory Affairs AI has fundamentally changed Regulatory Affairs. It’s time for an end-to-end, AI-forward approach that lets you drive unmatched value across the Regulatory lifecycle. Download Checklist Transform pharma compliance with GenAI-driven automation—streamline workflows, cut costs, and stay ahead of evolving regulations. Watch Now (486 words) - [Regulatory Submission Publishing | ArisGlobal](/content/lifesphere/regulatory/submission/index.html) (381 words) - [Contact Us | ArisGlobal](/content/contact-us/index.html): Connect With Us An Office In A City Near You. Boston, MA Corporate Headquarters ArisGlobal LLC201 Jones Road, 3rd FL EastWaltham, MA 02451United States+1 609-360-4042 Wolverhampton ArisGlobal UK LtdRegus Wolverhampton Salop StreetFloors, ArisGlobal (223 words) - [Who We Are | ArisGlobal](/content/who-we-are/index.html): ArisGlobal is a technology company at the forefront of life sciences. Mission-Critical Technology for Life Sciences R&D ArisGlobal is a pivotal partner in the life sciences industry, specializing in solutions that drive drug development, safety monitoring, and regulatory compliance. We collaborate with more (348 words) - [Future-Proof Your Regulatory Compliance: Critical Insights for 2025 and Beyond | ArisGlobal](/content/resources/future-proof-your-regulatory-compliance-critical-insights-for-2025-and-beyond.html) (135 words) - [Careers | ArisGlobal](/content/careers/index.html): You want to play a role in advancing the future of health? A place for innovators, thinkers, and creatorsArisGlobal is a life sciences technology pioneer with a mission to improve global health. Our technology is powerful, and so are our people. Join our (326 words) - [Resources Center | ArisGlobal](/content/resources-center/index.html) (151 words) - [wp-content/uploads/2026/07/ai-trust-center-faq-pdf.html](/content/wp-content/uploads/2026/07/ai-trust-center-faq-pdf.html) (509 words) - [RapidPV: Delivering Safety Databases at Speed  | ArisGlobal](/content/blogs/rapidpv-delivering-safety-databases-at-speed/index.html): At ArisGlobal, innovation has never been just about the technology itself. It has always been just as much about how we get that technology into our customers' hands, quickly, cost-effectively, and in a way that lets them stay focused on the work that actually matters: bringing life-saving therapies to patients. RapidPV, our fast-delivery model for, Realizing the full potential of AI in pharmacovigilance is about more than just choosing the right technology. Whether you're building, implementing, or scaling your AI strategy in PV, there are 10 critical questions teams should ask when evaluating AI-enabled technology partners. From assessing controls and outsights to understanding how architecture can scale to support enterprise deployment over time, you will find these 10 questions (and much more) in our newest guide, the AI Integration Roadmap for Pharmacovigilance. Download it now to dive in: https://lnkd.in/gqDU7sGb , On October 1st, join industry peers and learn how dozens of leading life sciences organizations are moving beyond individual use cases in PV workflows toward a fully AI-powered PV operations model delivering tangible results. During this session, we’ll explore how NavaX AI-powered capabilities are already helping organizations: ✔️ Accelerate case intake with advanced AI delivering efficiency gains of 30% ✔️ Capture critical safety information while reducing manual effort with Dynamic Data Extraction, enabling faster case intake with 95% accuracy ✔️ Improve consistency and efficiency with AI Narrative Generation, achieving a 90% narrative similarity score ✔️ Optimize field case reporting with ReporterX and the latest NavaX Companion Agent, delivering 65% efficiency gains through advanced AI ✔️ Accelerate signal and risk management with Signal Agents, delivering context-aware insights and decision support in minutes rather than hours Secure your spot: https://lnkd.in/gzHAUu4Z (1,738 words, 2026-09-17) - [Enhancing Your Existing RIM System with Modular, AI-Powered Innovation | ArisGlobal](/content/blogs/enhancing-your-existing-rim-system-with-modular-ai-powered-innovation.html): Regulatory pressure is intensifying across life sciences, as organizations large and small need to monitor constant changing regulations to ensure registrations and submissions remain in compliance with the latest guidelines, including urgent ISO and IDMP mandates, and other ever-evolving regulations across global markets.In this blog, we discuss how the availability of modular, AI-powered solutions like SPORIFY and Regulatory Intelligence, Realizing the full potential of AI in pharmacovigilance is about more than just choosing the right technology. Whether you're building, implementing, or scaling your AI strategy in PV, there are 10 critical questions teams should ask when evaluating AI-enabled technology partners. From assessing controls and outsights to understanding how architecture can scale to support enterprise deployment over time, you will find these 10 questions (and much more) in our newest guide, the AI Integration Roadmap for Pharmacovigilance. Download it now to dive in: https://lnkd.in/gqDU7sGb , On October 1st, join industry peers and learn how dozens of leading life sciences organizations are moving beyond individual use cases in PV workflows toward a fully AI-powered PV operations model delivering tangible results. During this session, we’ll explore how NavaX AI-powered capabilities are already helping organizations: ✔️ Accelerate case intake with advanced AI delivering efficiency gains of 30% ✔️ Capture critical safety information while reducing manual effort with Dynamic Data Extraction, enabling faster case intake with 95% accuracy ✔️ Improve consistency and efficiency with AI Narrative Generation, achieving a 90% narrative similarity score ✔️ Optimize field case reporting with ReporterX and the latest NavaX Companion Agent, delivering 65% efficiency gains through advanced AI ✔️ Accelerate signal and risk management with Signal Agents, delivering context-aware insights and decision support in minutes rather than hours Secure your spot: https://lnkd.in/gzHAUu4Z (714 words, 2026-04-20) - [Employing Generative AI to Drive Connected Regulatory Intelligence | ArisGlobal](/content/blogs/employing-generative-ai-to-drive-connected-regulatory-intelligence.html): Learn how leading firms are driving enhanced compliance using advanced automation to monitor for regulatory updates and built a regulatory intelligence knowledgebase. As Life Sciences firms need to generate more efficient and consistent compliance amid ever-evolving Agency mandates, there is a real opportunity to leverage innovations in artificial intelligence (AI) and generative AI (GenAI) to drive, Realizing the full potential of AI in pharmacovigilance is about more than just choosing the right technology. Whether you're building, implementing, or scaling your AI strategy in PV, there are 10 critical questions teams should ask when evaluating AI-enabled technology partners. From assessing controls and outsights to understanding how architecture can scale to support enterprise deployment over time, you will find these 10 questions (and much more) in our newest guide, the AI Integration Roadmap for Pharmacovigilance. Download it now to dive in: https://lnkd.in/gqDU7sGb , On October 1st, join industry peers and learn how dozens of leading life sciences organizations are moving beyond individual use cases in PV workflows toward a fully AI-powered PV operations model delivering tangible results. During this session, we’ll explore how NavaX AI-powered capabilities are already helping organizations: ✔️ Accelerate case intake with advanced AI delivering efficiency gains of 30% ✔️ Capture critical safety information while reducing manual effort with Dynamic Data Extraction, enabling faster case intake with 95% accuracy ✔️ Improve consistency and efficiency with AI Narrative Generation, achieving a 90% narrative similarity score ✔️ Optimize field case reporting with ReporterX and the latest NavaX Companion Agent, delivering 65% efficiency gains through advanced AI ✔️ Accelerate signal and risk management with Signal Agents, delivering context-aware insights and decision support in minutes rather than hours Secure your spot: https://lnkd.in/gzHAUu4Z (863 words, 2024-10-01) - [Breakthrough2022 | ArisGlobal](/content/blogs/breakthrough2022/index.html): October 3rd, 2022Boston, MA, USAArisGlobal’s Breakthrough2022 event will bring together key members of the life sciences and digital health community to provide insights into innovation, AI and digital transformation. This year’s event will feature sessions and keynotes by leading voices from across the industry, aimed at sharing ideas, experiences, and best practices.Sign Up Today, Realizing the full potential of AI in pharmacovigilance is about more than just choosing the right technology. Whether you're building, implementing, or scaling your AI strategy in PV, there are 10 critical questions teams should ask when evaluating AI-enabled technology partners. From assessing controls and outsights to understanding how architecture can scale to support enterprise deployment over time, you will find these 10 questions (and much more) in our newest guide, the AI Integration Roadmap for Pharmacovigilance. Download it now to dive in: https://lnkd.in/gqDU7sGb , On October 1st, join industry peers and learn how dozens of leading life sciences organizations are moving beyond individual use cases in PV workflows toward a fully AI-powered PV operations model delivering tangible results. During this session, we’ll explore how NavaX AI-powered capabilities are already helping organizations: ✔️ Accelerate case intake with advanced AI delivering efficiency gains of 30% ✔️ Capture critical safety information while reducing manual effort with Dynamic Data Extraction, enabling faster case intake with 95% accuracy ✔️ Improve consistency and efficiency with AI Narrative Generation, achieving a 90% narrative similarity score ✔️ Optimize field case reporting with ReporterX and the latest NavaX Companion Agent, delivering 65% efficiency gains through advanced AI ✔️ Accelerate signal and risk management with Signal Agents, delivering context-aware insights and decision support in minutes rather than hours Secure your spot: https://lnkd.in/gzHAUu4Z (117 words, 2022-10-03) - [LifeSphere Safety | ArisGlobal](/content/blogs/lifesphere-safety/index.html): Realizing the full potential of AI in pharmacovigilance is about more than just choosing the right technology. Whether you're building, implementing, or scaling your AI strategy in PV, there are 10 critical questions teams should ask when evaluating AI-enabled technology partners. From assessing controls and outsights to understanding how architecture can scale to support enterprise deployment over time, you will find these 10 questions (and much more) in our newest guide, the AI Integration Roadmap for Pharmacovigilance. Download it now to dive in: https://lnkd.in/gqDU7sGb , On October 1st, join industry peers and learn how dozens of leading life sciences organizations are moving beyond individual use cases in PV workflows toward a fully AI-powered PV operations model delivering tangible results. During this session, we’ll explore how NavaX AI-powered capabilities are already helping organizations: ✔️ Accelerate case intake with advanced AI delivering efficiency gains of 30% ✔️ Capture critical safety information while reducing manual effort with Dynamic Data Extraction, enabling faster case intake with 95% accuracy ✔️ Improve consistency and efficiency with AI Narrative Generation, achieving a 90% narrative similarity score ✔️ Optimize field case reporting with ReporterX and the latest NavaX Companion Agent, delivering 65% efficiency gains through advanced AI ✔️ Accelerate signal and risk management with Signal Agents, delivering context-aware insights and decision support in minutes rather than hours Secure your spot: https://lnkd.in/gzHAUu4Z (137 words, 2021-03-26) - [Digitization Changing the Regulatory Affairs Role | ArisGlobal](/content/blogs/arisglobal-viewpoint-how-digitization-changes-the-role-of-regulatory-affairs.html): The positive digital disruptions taking place within Regulatory Affairs will impact how we work, collaborate and share in Life Sciences and healthcare industries. Read the Blog, This is the last in the ArisGlobal three-part blog series on Regulatory Affairs transformation. Digitization is sweeping the life sciences industry, disrupting traditional working, Realizing the full potential of AI in pharmacovigilance is about more than just choosing the right technology. Whether you're building, implementing, or scaling your AI strategy in PV, there are 10 critical questions teams should ask when evaluating AI-enabled technology partners. From assessing controls and outsights to understanding how architecture can scale to support enterprise deployment over time, you will find these 10 questions (and much more) in our newest guide, the AI Integration Roadmap for Pharmacovigilance. Download it now to dive in: https://lnkd.in/gqDU7sGb , On October 1st, join industry peers and learn how dozens of leading life sciences organizations are moving beyond individual use cases in PV workflows toward a fully AI-powered PV operations model delivering tangible results. During this session, we’ll explore how NavaX AI-powered capabilities are already helping organizations: ✔️ Accelerate case intake with advanced AI delivering efficiency gains of 30% ✔️ Capture critical safety information while reducing manual effort with Dynamic Data Extraction, enabling faster case intake with 95% accuracy ✔️ Improve consistency and efficiency with AI Narrative Generation, achieving a 90% narrative similarity score ✔️ Optimize field case reporting with ReporterX and the latest NavaX Companion Agent, delivering 65% efficiency gains through advanced AI ✔️ Accelerate signal and risk management with Signal Agents, delivering context-aware insights and decision support in minutes rather than hours Secure your spot: https://lnkd.in/gzHAUu4Z (574 words, 2017-04-24) - [ArisGlobal expert shares how Regulatory Affairs needs to adapt change | ArisGlobal](/content/blogs/regulatory-affairs-needs-adapt-transformation-change.html): ArisGlobal expert shares how Regulatory Affairs needs to adapt to transformational change for life sciences companies to succeed. Read the Blog, The life sciences industry is confronting a wave of transformational change, brought about by multiple factors, including the growth of new clinical trial markets, a rapid rise in drug development innovation, reimbursement challenges, heightened regulatory requirements and a demand for evidence-based medicine, among many others. These drivers and the resultant changes are having a profound, Realizing the full potential of AI in pharmacovigilance is about more than just choosing the right technology. Whether you're building, implementing, or scaling your AI strategy in PV, there are 10 critical questions teams should ask when evaluating AI-enabled technology partners. From assessing controls and outsights to understanding how architecture can scale to support enterprise deployment over time, you will find these 10 questions (and much more) in our newest guide, the AI Integration Roadmap for Pharmacovigilance. Download it now to dive in: https://lnkd.in/gqDU7sGb , On October 1st, join industry peers and learn how dozens of leading life sciences organizations are moving beyond individual use cases in PV workflows toward a fully AI-powered PV operations model delivering tangible results. During this session, we’ll explore how NavaX AI-powered capabilities are already helping organizations: ✔️ Accelerate case intake with advanced AI delivering efficiency gains of 30% ✔️ Capture critical safety information while reducing manual effort with Dynamic Data Extraction, enabling faster case intake with 95% accuracy ✔️ Improve consistency and efficiency with AI Narrative Generation, achieving a 90% narrative similarity score ✔️ Optimize field case reporting with ReporterX and the latest NavaX Companion Agent, delivering 65% efficiency gains through advanced AI ✔️ Accelerate signal and risk management with Signal Agents, delivering context-aware insights and decision support in minutes rather than hours Secure your spot: https://lnkd.in/gzHAUu4Z (538 words, 2017-04-17) - [Regulatory Affairs Should Respond to Strategic Business Drivers | ArisGlobal](/content/blogs/think-big-regulatory-affairs-must-prepare-respond-strategic-business-drivers.html): ArisGlobal expert shares how life science organizations should prepare for 2020 regulatory affairs RIMS technology landscape. Read the Blog, Regulatory affairs departments are accustomed – and even open -- to change and adapting their technology and processes in response to compliance and business pressures. Typically, regulatory affairs leaders respond to such drivers as “how do we improve efficiency?,” “how do we speed the process to improve time to market?,” and “what do we need, Realizing the full potential of AI in pharmacovigilance is about more than just choosing the right technology. Whether you're building, implementing, or scaling your AI strategy in PV, there are 10 critical questions teams should ask when evaluating AI-enabled technology partners. From assessing controls and outsights to understanding how architecture can scale to support enterprise deployment over time, you will find these 10 questions (and much more) in our newest guide, the AI Integration Roadmap for Pharmacovigilance. Download it now to dive in: https://lnkd.in/gqDU7sGb , On October 1st, join industry peers and learn how dozens of leading life sciences organizations are moving beyond individual use cases in PV workflows toward a fully AI-powered PV operations model delivering tangible results. During this session, we’ll explore how NavaX AI-powered capabilities are already helping organizations: ✔️ Accelerate case intake with advanced AI delivering efficiency gains of 30% ✔️ Capture critical safety information while reducing manual effort with Dynamic Data Extraction, enabling faster case intake with 95% accuracy ✔️ Improve consistency and efficiency with AI Narrative Generation, achieving a 90% narrative similarity score ✔️ Optimize field case reporting with ReporterX and the latest NavaX Companion Agent, delivering 65% efficiency gains through advanced AI ✔️ Accelerate signal and risk management with Signal Agents, delivering context-aware insights and decision support in minutes rather than hours Secure your spot: https://lnkd.in/gzHAUu4Z (449 words, 2017-04-10) - [A Secret Weapon to Act on your IDMP Assessment | ArisGlobal](/content/blogs/secret-weapon-act-idmp-assessment/index.html): What does It mean to use technology solutions to solve your IDMP assessment? Read this ArisGlobal blog to learn how to leverage this “secret weapon.”, If you’re in Regulatory Affairs, you know the IDMP-compliance-truck is headed your way. Which questions though are plaguing your team? Wondering how to work on the recommendations from an initial IDMP Readiness Assessment? Still evaluating if an initial IDMP-readiness assessment will give you concrete visibility on how you will tackle the, Realizing the full potential of AI in pharmacovigilance is about more than just choosing the right technology. Whether you're building, implementing, or scaling your AI strategy in PV, there are 10 critical questions teams should ask when evaluating AI-enabled technology partners. From assessing controls and outsights to understanding how architecture can scale to support enterprise deployment over time, you will find these 10 questions (and much more) in our newest guide, the AI Integration Roadmap for Pharmacovigilance. Download it now to dive in: https://lnkd.in/gqDU7sGb , On October 1st, join industry peers and learn how dozens of leading life sciences organizations are moving beyond individual use cases in PV workflows toward a fully AI-powered PV operations model delivering tangible results. During this session, we’ll explore how NavaX AI-powered capabilities are already helping organizations: ✔️ Accelerate case intake with advanced AI delivering efficiency gains of 30% ✔️ Capture critical safety information while reducing manual effort with Dynamic Data Extraction, enabling faster case intake with 95% accuracy ✔️ Improve consistency and efficiency with AI Narrative Generation, achieving a 90% narrative similarity score ✔️ Optimize field case reporting with ReporterX and the latest NavaX Companion Agent, delivering 65% efficiency gains through advanced AI ✔️ Accelerate signal and risk management with Signal Agents, delivering context-aware insights and decision support in minutes rather than hours Secure your spot: https://lnkd.in/gzHAUu4Z (694 words, 2017-04-05) - [Drug Adverse Event Reporting Software is Now Mobile-Friendly | ArisGlobal](/content/blogs/adverse-event-reporting-software-goes-mobile/index.html): Adverse event reporting software with mobile reporting functionality makes easier for MSLs/ HCPs to identify and report potential adverse events promptly, Every one of us at some point will take a medication and likely suffer some sort of adverse reaction. However, while some of us will actually read the product label and identify the possible adverse reactions, only a handful of us will ever report our experiences to the manufacturer. This lack of adverse event reporting, Realizing the full potential of AI in pharmacovigilance is about more than just choosing the right technology. Whether you're building, implementing, or scaling your AI strategy in PV, there are 10 critical questions teams should ask when evaluating AI-enabled technology partners. From assessing controls and outsights to understanding how architecture can scale to support enterprise deployment over time, you will find these 10 questions (and much more) in our newest guide, the AI Integration Roadmap for Pharmacovigilance. Download it now to dive in: https://lnkd.in/gqDU7sGb , On October 1st, join industry peers and learn how dozens of leading life sciences organizations are moving beyond individual use cases in PV workflows toward a fully AI-powered PV operations model delivering tangible results. During this session, we’ll explore how NavaX AI-powered capabilities are already helping organizations: ✔️ Accelerate case intake with advanced AI delivering efficiency gains of 30% ✔️ Capture critical safety information while reducing manual effort with Dynamic Data Extraction, enabling faster case intake with 95% accuracy ✔️ Improve consistency and efficiency with AI Narrative Generation, achieving a 90% narrative similarity score ✔️ Optimize field case reporting with ReporterX and the latest NavaX Companion Agent, delivering 65% efficiency gains through advanced AI ✔️ Accelerate signal and risk management with Signal Agents, delivering context-aware insights and decision support in minutes rather than hours Secure your spot: https://lnkd.in/gzHAUu4Z (508 words, 2017-03-22) - [New Rules Challenging Data Privacy Retention Processes | ArisGlobal](/content/blogs/new-rules-challenging-data-privacy/index.html): Data privacy retention processes are becoming more complicated for medical affairs & pharmacovigilance. Is there a solution? Read the Blog, What are the Challenges in the Pharma Industry Regarding Data Privacy?Data privacy and data retention seem to become more complicated by the day in the realm of medical affairs and pharmacovigilance. I am beginning to think that there really is no solution. With the GDPR (General Data Protection Regulation) coming in 2018 followed by Brexit I, Realizing the full potential of AI in pharmacovigilance is about more than just choosing the right technology. Whether you're building, implementing, or scaling your AI strategy in PV, there are 10 critical questions teams should ask when evaluating AI-enabled technology partners. From assessing controls and outsights to understanding how architecture can scale to support enterprise deployment over time, you will find these 10 questions (and much more) in our newest guide, the AI Integration Roadmap for Pharmacovigilance. Download it now to dive in: https://lnkd.in/gqDU7sGb , On October 1st, join industry peers and learn how dozens of leading life sciences organizations are moving beyond individual use cases in PV workflows toward a fully AI-powered PV operations model delivering tangible results. During this session, we’ll explore how NavaX AI-powered capabilities are already helping organizations: ✔️ Accelerate case intake with advanced AI delivering efficiency gains of 30% ✔️ Capture critical safety information while reducing manual effort with Dynamic Data Extraction, enabling faster case intake with 95% accuracy ✔️ Improve consistency and efficiency with AI Narrative Generation, achieving a 90% narrative similarity score ✔️ Optimize field case reporting with ReporterX and the latest NavaX Companion Agent, delivering 65% efficiency gains through advanced AI ✔️ Accelerate signal and risk management with Signal Agents, delivering context-aware insights and decision support in minutes rather than hours Secure your spot: https://lnkd.in/gzHAUu4Z (455 words, 2017-03-21) - [Regulatory Information Management: Solving the Compliance Challenge | ArisGlobal](/content/blogs/regulatory-information-management-solving-compliance-challenge-new-approach.html): A preview of DIA’s upcoming Regulatory Conference, where ArisGlobal will unveil its revolutionary regulatory information management system software. Read the Blog, A preview of DIA’s upcoming Regulatory Conference, where ArisGlobal will unveil its revolutionary regulatory information management system software.It’s no secret, the main role of any pharmaceutical company’s regulatory affairs (RA) department is to interact with the regulators of different countries throughout the development, registration and marketing phase of the product life cycle – all with the goal, Realizing the full potential of AI in pharmacovigilance is about more than just choosing the right technology. Whether you're building, implementing, or scaling your AI strategy in PV, there are 10 critical questions teams should ask when evaluating AI-enabled technology partners. From assessing controls and outsights to understanding how architecture can scale to support enterprise deployment over time, you will find these 10 questions (and much more) in our newest guide, the AI Integration Roadmap for Pharmacovigilance. Download it now to dive in: https://lnkd.in/gqDU7sGb , On October 1st, join industry peers and learn how dozens of leading life sciences organizations are moving beyond individual use cases in PV workflows toward a fully AI-powered PV operations model delivering tangible results. During this session, we’ll explore how NavaX AI-powered capabilities are already helping organizations: ✔️ Accelerate case intake with advanced AI delivering efficiency gains of 30% ✔️ Capture critical safety information while reducing manual effort with Dynamic Data Extraction, enabling faster case intake with 95% accuracy ✔️ Improve consistency and efficiency with AI Narrative Generation, achieving a 90% narrative similarity score ✔️ Optimize field case reporting with ReporterX and the latest NavaX Companion Agent, delivering 65% efficiency gains through advanced AI ✔️ Accelerate signal and risk management with Signal Agents, delivering context-aware insights and decision support in minutes rather than hours Secure your spot: https://lnkd.in/gzHAUu4Z (456 words, 2017-03-21) - [Press Release: Clinical Research IO to Collaborate with ArisGlobal | ArisGlobal](/content/media/press-release/clinical-research-io-collaborate-arisglobal-improve-data-quality-reduce-costly-overhead-involved-clinical-research.html): Clinical Research IO (CRIO) announced announced that it will collaborate with ArisGlobal to streamline clinical research. Read here, CAMBRIDGE, MA. March 16, 2017-- Clinical Research IO (CRIO), a Cambridge-based technology company that has developed the first eSource system built and marketed directly to clinical research sites, announced today that it will collaborate with ArisGlobal to streamline clinical research.CRIO’s system replaces the paper forms used at many research sites with an interactive web and, Realizing the full potential of AI in pharmacovigilance is about more than just choosing the right technology. Whether you're building, implementing, or scaling your AI strategy in PV, there are 10 critical questions teams should ask when evaluating AI-enabled technology partners. From assessing controls and outsights to understanding how architecture can scale to support enterprise deployment over time, you will find these 10 questions (and much more) in our newest guide, the AI Integration Roadmap for Pharmacovigilance. Download it now to dive in: https://lnkd.in/gqDU7sGb , On October 1st, join industry peers and learn how dozens of leading life sciences organizations are moving beyond individual use cases in PV workflows toward a fully AI-powered PV operations model delivering tangible results. During this session, we’ll explore how NavaX AI-powered capabilities are already helping organizations: ✔️ Accelerate case intake with advanced AI delivering efficiency gains of 30% ✔️ Capture critical safety information while reducing manual effort with Dynamic Data Extraction, enabling faster case intake with 95% accuracy ✔️ Improve consistency and efficiency with AI Narrative Generation, achieving a 90% narrative similarity score ✔️ Optimize field case reporting with ReporterX and the latest NavaX Companion Agent, delivering 65% efficiency gains through advanced AI ✔️ Accelerate signal and risk management with Signal Agents, delivering context-aware insights and decision support in minutes rather than hours Secure your spot: https://lnkd.in/gzHAUu4Z (445 words, 2017-03-16) - [How Regulatory Information Management Simplifies Requirements for Medical Devices | ArisGlobal](/content/blogs/getting-ready-udi-regulatory-information-management-simplifies-requirements-medical-devices.html): Keeping track of information required to manage your medical devices on the market is a complex task. Learn more about regulatory information management software with ArisGlobal., Keeping track of all the information required to manage your medical devices on the market is a hugely complex task, and is becoming progressively more difficult. Growth in your product portfolio means a higher volume of data to manage, tighter regulatory requirements create stricter timelines and oversight for products on the market, and more stringent, Realizing the full potential of AI in pharmacovigilance is about more than just choosing the right technology. Whether you're building, implementing, or scaling your AI strategy in PV, there are 10 critical questions teams should ask when evaluating AI-enabled technology partners. From assessing controls and outsights to understanding how architecture can scale to support enterprise deployment over time, you will find these 10 questions (and much more) in our newest guide, the AI Integration Roadmap for Pharmacovigilance. Download it now to dive in: https://lnkd.in/gqDU7sGb , On October 1st, join industry peers and learn how dozens of leading life sciences organizations are moving beyond individual use cases in PV workflows toward a fully AI-powered PV operations model delivering tangible results. During this session, we’ll explore how NavaX AI-powered capabilities are already helping organizations: ✔️ Accelerate case intake with advanced AI delivering efficiency gains of 30% ✔️ Capture critical safety information while reducing manual effort with Dynamic Data Extraction, enabling faster case intake with 95% accuracy ✔️ Improve consistency and efficiency with AI Narrative Generation, achieving a 90% narrative similarity score ✔️ Optimize field case reporting with ReporterX and the latest NavaX Companion Agent, delivering 65% efficiency gains through advanced AI ✔️ Accelerate signal and risk management with Signal Agents, delivering context-aware insights and decision support in minutes rather than hours Secure your spot: https://lnkd.in/gzHAUu4Z (695 words, 2017-02-21) - [A Look Back at Partnerships in Clinical Trials Europe | ArisGlobal](/content/blogs/look-back-partnerships-clinical-trials-europe/index.html): A recap of the 2016 Partnerships in Clinical Trials Europe conference and the unique challenges faced by CROs. Read the Blog to learn more., By Danilo PavlovicAs both a conference attendee and ArisGlobal representative in our booth on the show floor at the recent Partnerships in Clinical Trials Europe, I had plenty of opportunity to sit in on sessions, talk to industry colleagues and meet with attendees. From show-floor chat, Realizing the full potential of AI in pharmacovigilance is about more than just choosing the right technology. Whether you're building, implementing, or scaling your AI strategy in PV, there are 10 critical questions teams should ask when evaluating AI-enabled technology partners. From assessing controls and outsights to understanding how architecture can scale to support enterprise deployment over time, you will find these 10 questions (and much more) in our newest guide, the AI Integration Roadmap for Pharmacovigilance. Download it now to dive in: https://lnkd.in/gqDU7sGb , On October 1st, join industry peers and learn how dozens of leading life sciences organizations are moving beyond individual use cases in PV workflows toward a fully AI-powered PV operations model delivering tangible results. During this session, we’ll explore how NavaX AI-powered capabilities are already helping organizations: ✔️ Accelerate case intake with advanced AI delivering efficiency gains of 30% ✔️ Capture critical safety information while reducing manual effort with Dynamic Data Extraction, enabling faster case intake with 95% accuracy ✔️ Improve consistency and efficiency with AI Narrative Generation, achieving a 90% narrative similarity score ✔️ Optimize field case reporting with ReporterX and the latest NavaX Companion Agent, delivering 65% efficiency gains through advanced AI ✔️ Accelerate signal and risk management with Signal Agents, delivering context-aware insights and decision support in minutes rather than hours Secure your spot: https://lnkd.in/gzHAUu4Z (493 words, 2017-01-10) - [If You’re a CRO, You’ll Want to Read This Success Story | ArisGlobal](/content/blogs/youre-cro-youll-want-read-success-story/index.html): ArisGlobal success story in partnership with global CRO in providing world class safety solution, Read our Blog, As the outsourcing trend continues to grow, many biopharmaceutical and pharmaceutical companies find themselves needing to partner with CROs (contract research organizations) that are seasoned and can provide broad areas of safety support. To meet these needs, CROs in turn have built capacities to ensure that they have a robust safety platform with a qualified, Realizing the full potential of AI in pharmacovigilance is about more than just choosing the right technology. Whether you're building, implementing, or scaling your AI strategy in PV, there are 10 critical questions teams should ask when evaluating AI-enabled technology partners. From assessing controls and outsights to understanding how architecture can scale to support enterprise deployment over time, you will find these 10 questions (and much more) in our newest guide, the AI Integration Roadmap for Pharmacovigilance. Download it now to dive in: https://lnkd.in/gqDU7sGb , On October 1st, join industry peers and learn how dozens of leading life sciences organizations are moving beyond individual use cases in PV workflows toward a fully AI-powered PV operations model delivering tangible results. During this session, we’ll explore how NavaX AI-powered capabilities are already helping organizations: ✔️ Accelerate case intake with advanced AI delivering efficiency gains of 30% ✔️ Capture critical safety information while reducing manual effort with Dynamic Data Extraction, enabling faster case intake with 95% accuracy ✔️ Improve consistency and efficiency with AI Narrative Generation, achieving a 90% narrative similarity score ✔️ Optimize field case reporting with ReporterX and the latest NavaX Companion Agent, delivering 65% efficiency gains through advanced AI ✔️ Accelerate signal and risk management with Signal Agents, delivering context-aware insights and decision support in minutes rather than hours Secure your spot: https://lnkd.in/gzHAUu4Z (288 words, 2017-01-06) - [Realizing the importance of emerging CROs | ArisGlobal](/content/blogs/level-playing-field-realizing-importance-of-emerging-cros.html): ArisGlobal’s Agile CRO program is a healthy technological proposition for emerging CROs to drive end-to-end clinical processes. Red our Blog, With declining R&D budgets, increased competition from larger CROs and patent expirations, emerging CROs have evolved from being non-core service providers to being integral partners in the earliest to the latest stages of the drug discovery and development process. According to a Grand View Research report, the global healthcare CRO market is expected to reach, Realizing the full potential of AI in pharmacovigilance is about more than just choosing the right technology. Whether you're building, implementing, or scaling your AI strategy in PV, there are 10 critical questions teams should ask when evaluating AI-enabled technology partners. From assessing controls and outsights to understanding how architecture can scale to support enterprise deployment over time, you will find these 10 questions (and much more) in our newest guide, the AI Integration Roadmap for Pharmacovigilance. Download it now to dive in: https://lnkd.in/gqDU7sGb , On October 1st, join industry peers and learn how dozens of leading life sciences organizations are moving beyond individual use cases in PV workflows toward a fully AI-powered PV operations model delivering tangible results. During this session, we’ll explore how NavaX AI-powered capabilities are already helping organizations: ✔️ Accelerate case intake with advanced AI delivering efficiency gains of 30% ✔️ Capture critical safety information while reducing manual effort with Dynamic Data Extraction, enabling faster case intake with 95% accuracy ✔️ Improve consistency and efficiency with AI Narrative Generation, achieving a 90% narrative similarity score ✔️ Optimize field case reporting with ReporterX and the latest NavaX Companion Agent, delivering 65% efficiency gains through advanced AI ✔️ Accelerate signal and risk management with Signal Agents, delivering context-aware insights and decision support in minutes rather than hours Secure your spot: https://lnkd.in/gzHAUu4Z (382 words, 2017-01-06) - [ArisGlobal Wins Growing Client Base for Drug Safety and Risk Management Platform agBalance | ArisGlobal](/content/media/press-release/arisglobal-wins-growing-client-base-drug-safety-risk-management-platform-agbalance.html): Companies Turn to Signal Detection and Risk Management Solution for Seamless Integration, End-to-End Safety Life Cycle Management, and Ease-of-Use., CHICAGO, IL.  January 3, 2017 -- ArisGlobal, a leading provider of cloud-based software solutions for the life sciences, has announced four new clients that are using its integrated safety intelligence, signal management and risk management platform agBalance.Several factors are prompting organizations to adopt agBalance: ease of integration with existing safety systems, its ability to manage, Realizing the full potential of AI in pharmacovigilance is about more than just choosing the right technology. Whether you're building, implementing, or scaling your AI strategy in PV, there are 10 critical questions teams should ask when evaluating AI-enabled technology partners. From assessing controls and outsights to understanding how architecture can scale to support enterprise deployment over time, you will find these 10 questions (and much more) in our newest guide, the AI Integration Roadmap for Pharmacovigilance. Download it now to dive in: https://lnkd.in/gqDU7sGb , On October 1st, join industry peers and learn how dozens of leading life sciences organizations are moving beyond individual use cases in PV workflows toward a fully AI-powered PV operations model delivering tangible results. During this session, we’ll explore how NavaX AI-powered capabilities are already helping organizations: ✔️ Accelerate case intake with advanced AI delivering efficiency gains of 30% ✔️ Capture critical safety information while reducing manual effort with Dynamic Data Extraction, enabling faster case intake with 95% accuracy ✔️ Improve consistency and efficiency with AI Narrative Generation, achieving a 90% narrative similarity score ✔️ Optimize field case reporting with ReporterX and the latest NavaX Companion Agent, delivering 65% efficiency gains through advanced AI ✔️ Accelerate signal and risk management with Signal Agents, delivering context-aware insights and decision support in minutes rather than hours Secure your spot: https://lnkd.in/gzHAUu4Z (534 words, 2017-01-03) - [Contract Research Organization (CRO) and R&D Trends | ArisGlobal](/content/blogs/cro-rd-trends/index.html): CRO (contract research organization) industry grows as increasingly complex R&D trends demand advanced expertise. Read our Blog., CRO industry grows as increasingly complex R&D trends demand advanced expertiseAmong today’s CRO, R&D trends, precision-based medicines and immunotherapies for smaller populations and treatments for rare diseases are driving innovation. Aside from the exorbitant costs tied to development, these treatments require advanced and integrated expertise. In an effort to contain costs and shorten development timelines, pharma and biopharma firms increasingly outsource, Realizing the full potential of AI in pharmacovigilance is about more than just choosing the right technology. Whether you're building, implementing, or scaling your AI strategy in PV, there are 10 critical questions teams should ask when evaluating AI-enabled technology partners. From assessing controls and outsights to understanding how architecture can scale to support enterprise deployment over time, you will find these 10 questions (and much more) in our newest guide, the AI Integration Roadmap for Pharmacovigilance. Download it now to dive in: https://lnkd.in/gqDU7sGb , On October 1st, join industry peers and learn how dozens of leading life sciences organizations are moving beyond individual use cases in PV workflows toward a fully AI-powered PV operations model delivering tangible results. During this session, we’ll explore how NavaX AI-powered capabilities are already helping organizations: ✔️ Accelerate case intake with advanced AI delivering efficiency gains of 30% ✔️ Capture critical safety information while reducing manual effort with Dynamic Data Extraction, enabling faster case intake with 95% accuracy ✔️ Improve consistency and efficiency with AI Narrative Generation, achieving a 90% narrative similarity score ✔️ Optimize field case reporting with ReporterX and the latest NavaX Companion Agent, delivering 65% efficiency gains through advanced AI ✔️ Accelerate signal and risk management with Signal Agents, delivering context-aware insights and decision support in minutes rather than hours Secure your spot: https://lnkd.in/gzHAUu4Z (226 words, 2017-01-02) - [Press Release: ArisGlobal Announces Clinical Research Organization Program | ArisGlobal](/content/media/press-release/arisglobal-announces-first-market-agile-clinical-research-organization-program.html): ArisGlobal, a leading provider of integrated, cloud-based software solutions for life sciences, has announced a one-of-a-kind Agile clinical research organization (CRO) solution platform that provides transformational clinical trial transparency solutions to CROs of all sizes to help them accelerate clinical trials and grow their business with their sponsors., Pay-As-You-Grow Service Offering Delivers Competitive Edge to CROs looking for more Sponsors and Clinical TrialsCHICAGO, IL.  DECEMBER 14, 2016 -- ArisGlobal, a leading provider of integrated, cloud-based software solutions for life sciences, has announced a one-of-a-kind Agile clinical research organization (CRO) solution platform that provides transformational clinical development solutions to CROs of all sizes to, Realizing the full potential of AI in pharmacovigilance is about more than just choosing the right technology. Whether you're building, implementing, or scaling your AI strategy in PV, there are 10 critical questions teams should ask when evaluating AI-enabled technology partners. From assessing controls and outsights to understanding how architecture can scale to support enterprise deployment over time, you will find these 10 questions (and much more) in our newest guide, the AI Integration Roadmap for Pharmacovigilance. Download it now to dive in: https://lnkd.in/gqDU7sGb , On October 1st, join industry peers and learn how dozens of leading life sciences organizations are moving beyond individual use cases in PV workflows toward a fully AI-powered PV operations model delivering tangible results. During this session, we’ll explore how NavaX AI-powered capabilities are already helping organizations: ✔️ Accelerate case intake with advanced AI delivering efficiency gains of 30% ✔️ Capture critical safety information while reducing manual effort with Dynamic Data Extraction, enabling faster case intake with 95% accuracy ✔️ Improve consistency and efficiency with AI Narrative Generation, achieving a 90% narrative similarity score ✔️ Optimize field case reporting with ReporterX and the latest NavaX Companion Agent, delivering 65% efficiency gains through advanced AI ✔️ Accelerate signal and risk management with Signal Agents, delivering context-aware insights and decision support in minutes rather than hours Secure your spot: https://lnkd.in/gzHAUu4Z (636 words, 2016-12-14) - [Webinar: Cosmetovigilance – Regulatory requirements & compliance through ARISg | ArisGlobal](/content/webinar/cosmetovigilance-regulatory-requirements-compliance-arisg.html): With an increased focus on cosmetovigilance driven by regulatory agencies across countries, the safety departments need to understand the impact of these regulations, the general cosmetovigilance process and ensure compliance. Watch this webinar to get insights on how LifeSphere Safety MultiVigilance (formerly knwon as ARISg) ensures regulatory compliance, With an increased focus on cosmetovigilance driven by regulatory agencies across countries, the safety departments need to understand the impact of these regulations, the general cosmetovigilance process and ensure compliance. Under the new EU Regulation (EC) No 1223/2009, cosmetic companies are required to have information clearly available to the Regulatory Authorities concerning their cosmetic products (293 words, 2016-11-17) - [ArisGlobal's Dr. Krishna Bahadursingh, Senior Vice President, Safety and Risk Management](/content/media/press-release/arisglobals-dr-krishna-bahadursingh-senior-vice-president-safety-risk-management-featured-japans-yakuji-nippo.html): Dr. Krishna joined ArisGlobal in Sept'16. He brings 17 years of drug safety and risk management experience to ArisGlobal’s Safety and Pharmacovigilance BU, Dr. Bahadursingh joined ArisGlobal in September, 2016, and brings more than 17 years of drug safety and risk management experience to ArisGlobal’s Safety and Pharmacovigilance business unit. The following is an English translation of a feature by Japan’s Yakuji NippoIT solution provider for pharmacovigilance and clinical safety, ArisGlobal KK, has appointed Dr. Krishna Bahadursingh as, Realizing the full potential of AI in pharmacovigilance is about more than just choosing the right technology. Whether you're building, implementing, or scaling your AI strategy in PV, there are 10 critical questions teams should ask when evaluating AI-enabled technology partners. From assessing controls and outsights to understanding how architecture can scale to support enterprise deployment over time, you will find these 10 questions (and much more) in our newest guide, the AI Integration Roadmap for Pharmacovigilance. Download it now to dive in: https://lnkd.in/gqDU7sGb , On October 1st, join industry peers and learn how dozens of leading life sciences organizations are moving beyond individual use cases in PV workflows toward a fully AI-powered PV operations model delivering tangible results. During this session, we’ll explore how NavaX AI-powered capabilities are already helping organizations: ✔️ Accelerate case intake with advanced AI delivering efficiency gains of 30% ✔️ Capture critical safety information while reducing manual effort with Dynamic Data Extraction, enabling faster case intake with 95% accuracy ✔️ Improve consistency and efficiency with AI Narrative Generation, achieving a 90% narrative similarity score ✔️ Optimize field case reporting with ReporterX and the latest NavaX Companion Agent, delivering 65% efficiency gains through advanced AI ✔️ Accelerate signal and risk management with Signal Agents, delivering context-aware insights and decision support in minutes rather than hours Secure your spot: https://lnkd.in/gzHAUu4Z (620 words, 2016-11-11) - [ArisGlobal Launches TotalSafety 7.3 | ArisGlobal](/content/media/press-release/arisglobal-launches-totalsafety-7-3/index.html): REGULATORY COMPLIANCE, INCREASED PRODUCTIVITY, QUALITY MANAGEMENT, AND LOWER TOTAL COST OF OWNERSHIP HIGHLIGHT PLATFORM UPGRADESChicago, Illinois, October 4, 2016 -- ArisGlobal announces the launch of TotalSafety 7.3, the latest enhancement to its comprehensive safety suite. Building upon industry-leading best practices, the fully cloud- and Single Application Instance (SAI)-based platform continues to meet the compliance requirements, Realizing the full potential of AI in pharmacovigilance is about more than just choosing the right technology. Whether you're building, implementing, or scaling your AI strategy in PV, there are 10 critical questions teams should ask when evaluating AI-enabled technology partners. From assessing controls and outsights to understanding how architecture can scale to support enterprise deployment over time, you will find these 10 questions (and much more) in our newest guide, the AI Integration Roadmap for Pharmacovigilance. Download it now to dive in: https://lnkd.in/gqDU7sGb , On October 1st, join industry peers and learn how dozens of leading life sciences organizations are moving beyond individual use cases in PV workflows toward a fully AI-powered PV operations model delivering tangible results. During this session, we’ll explore how NavaX AI-powered capabilities are already helping organizations: ✔️ Accelerate case intake with advanced AI delivering efficiency gains of 30% ✔️ Capture critical safety information while reducing manual effort with Dynamic Data Extraction, enabling faster case intake with 95% accuracy ✔️ Improve consistency and efficiency with AI Narrative Generation, achieving a 90% narrative similarity score ✔️ Optimize field case reporting with ReporterX and the latest NavaX Companion Agent, delivering 65% efficiency gains through advanced AI ✔️ Accelerate signal and risk management with Signal Agents, delivering context-aware insights and decision support in minutes rather than hours Secure your spot: https://lnkd.in/gzHAUu4Z (489 words, 2016-10-04) - [Solidifying Growth Strategy, ArisGlobal Hires Dr. Krishna Bahadursingh to Head Safety and Pharmacovigilance Business Unit | ArisGlobal](/content/media/press-release/solidifying-growth-strategy-arisglobal-hires-dr-krishna-bahadursingh-head-safety-pharmacovigilance-business-unit.html): September 23, 2016 – ArisGlobal®, a leading provider of integrated, cloud-based software solutions for life sciences, today welcomes Dr. Krishna Bahadursingh as the organization’s Senior Vice President of Safety and Risk Management. As a preeminent expert in safety and pharmacovigilance, Dr. Bahadursingh brings more than 17 years of experience to ArisGlobal’s leadership team, most recently, Realizing the full potential of AI in pharmacovigilance is about more than just choosing the right technology. Whether you're building, implementing, or scaling your AI strategy in PV, there are 10 critical questions teams should ask when evaluating AI-enabled technology partners. From assessing controls and outsights to understanding how architecture can scale to support enterprise deployment over time, you will find these 10 questions (and much more) in our newest guide, the AI Integration Roadmap for Pharmacovigilance. Download it now to dive in: https://lnkd.in/gqDU7sGb , On October 1st, join industry peers and learn how dozens of leading life sciences organizations are moving beyond individual use cases in PV workflows toward a fully AI-powered PV operations model delivering tangible results. During this session, we’ll explore how NavaX AI-powered capabilities are already helping organizations: ✔️ Accelerate case intake with advanced AI delivering efficiency gains of 30% ✔️ Capture critical safety information while reducing manual effort with Dynamic Data Extraction, enabling faster case intake with 95% accuracy ✔️ Improve consistency and efficiency with AI Narrative Generation, achieving a 90% narrative similarity score ✔️ Optimize field case reporting with ReporterX and the latest NavaX Companion Agent, delivering 65% efficiency gains through advanced AI ✔️ Accelerate signal and risk management with Signal Agents, delivering context-aware insights and decision support in minutes rather than hours Secure your spot: https://lnkd.in/gzHAUu4Z (452 words, 2016-09-26) - [Press Release: CSC in Collaboration with ArisGlobal launch IDMP | ArisGlobal](/content/media/press-release/csc-launches-identification-of-medicinal-products-idmp-as-a-service.html): CSC launches Identification of Medicinal Products As-a Service (IDMPaaS) in collaboration with ArisGlobal to deliver a cloud-hosted offering, New Life Sciences Solution Supports, Enables and Simplifies Compliance Acrossall Four Stages of the IDMP Maturity Curve with a Single PlatformTYSONS, Va., June 27, 2016 – CSC (NYSE: CSC), a global leader in next-generation IT services and solutions, today announced the launch of Identification of Medicinal Products As-a, Realizing the full potential of AI in pharmacovigilance is about more than just choosing the right technology. Whether you're building, implementing, or scaling your AI strategy in PV, there are 10 critical questions teams should ask when evaluating AI-enabled technology partners. From assessing controls and outsights to understanding how architecture can scale to support enterprise deployment over time, you will find these 10 questions (and much more) in our newest guide, the AI Integration Roadmap for Pharmacovigilance. Download it now to dive in: https://lnkd.in/gqDU7sGb , On October 1st, join industry peers and learn how dozens of leading life sciences organizations are moving beyond individual use cases in PV workflows toward a fully AI-powered PV operations model delivering tangible results. During this session, we’ll explore how NavaX AI-powered capabilities are already helping organizations: ✔️ Accelerate case intake with advanced AI delivering efficiency gains of 30% ✔️ Capture critical safety information while reducing manual effort with Dynamic Data Extraction, enabling faster case intake with 95% accuracy ✔️ Improve consistency and efficiency with AI Narrative Generation, achieving a 90% narrative similarity score ✔️ Optimize field case reporting with ReporterX and the latest NavaX Companion Agent, delivering 65% efficiency gains through advanced AI ✔️ Accelerate signal and risk management with Signal Agents, delivering context-aware insights and decision support in minutes rather than hours Secure your spot: https://lnkd.in/gzHAUu4Z (884 words, 2016-06-28) - [Tech Mahindra and ArisGlobal Partner to Provide the Life Sciences Industry with an End-to-End Solution for IDMP Compliance | ArisGlobal](/content/media/press-release/tech-mahindra-and-arisglobal-partner-to-provide-the-life-sciences-industry-with-an-end-to-end-solution-for-idmp-compliance.html): ArisGlobal®, a leading provider of cloud-based software solutions for life sciences and Tech Mahindra Limited, a leading provider of IT, Networks & Engineering solutions and BPO services have partnered to provide the life sciences industry with a complete end-to-end solution that addresses IDMP regulatory compliance requirements and provides a solution which will improve efficiencies and, Realizing the full potential of AI in pharmacovigilance is about more than just choosing the right technology. Whether you're building, implementing, or scaling your AI strategy in PV, there are 10 critical questions teams should ask when evaluating AI-enabled technology partners. From assessing controls and outsights to understanding how architecture can scale to support enterprise deployment over time, you will find these 10 questions (and much more) in our newest guide, the AI Integration Roadmap for Pharmacovigilance. Download it now to dive in: https://lnkd.in/gqDU7sGb , On October 1st, join industry peers and learn how dozens of leading life sciences organizations are moving beyond individual use cases in PV workflows toward a fully AI-powered PV operations model delivering tangible results. During this session, we’ll explore how NavaX AI-powered capabilities are already helping organizations: ✔️ Accelerate case intake with advanced AI delivering efficiency gains of 30% ✔️ Capture critical safety information while reducing manual effort with Dynamic Data Extraction, enabling faster case intake with 95% accuracy ✔️ Improve consistency and efficiency with AI Narrative Generation, achieving a 90% narrative similarity score ✔️ Optimize field case reporting with ReporterX and the latest NavaX Companion Agent, delivering 65% efficiency gains through advanced AI ✔️ Accelerate signal and risk management with Signal Agents, delivering context-aware insights and decision support in minutes rather than hours Secure your spot: https://lnkd.in/gzHAUu4Z (398 words, 2016-06-20) - [Webinar: Integration Paves the Way: Overcoming Clinical Challenges & Complexities | ArisGlobal](/content/blogs/integration-paves-the-way-overcoming-the-challenges-complexities-of-todays-clinical-development-environment.html): Clinical development challenges have never been tougher and more complex, forcing sponsors to be smarter and more creative in how they conduct and manage clinical research. Watch this webinar to understand how technology can you easily and efficiently overcome the clinical disconnect, Clinical development challenges have never been tougher and more complex, forcing sponsors to be smarter and more creative in how they conduct and manage clinical research. But with the deployment of diverse clinical systems from different vendors, using different technology, how can you easily and efficiently overcome the clinical, Realizing the full potential of AI in pharmacovigilance is about more than just choosing the right technology. Whether you're building, implementing, or scaling your AI strategy in PV, there are 10 critical questions teams should ask when evaluating AI-enabled technology partners. From assessing controls and outsights to understanding how architecture can scale to support enterprise deployment over time, you will find these 10 questions (and much more) in our newest guide, the AI Integration Roadmap for Pharmacovigilance. Download it now to dive in: https://lnkd.in/gqDU7sGb , On October 1st, join industry peers and learn how dozens of leading life sciences organizations are moving beyond individual use cases in PV workflows toward a fully AI-powered PV operations model delivering tangible results. During this session, we’ll explore how NavaX AI-powered capabilities are already helping organizations: ✔️ Accelerate case intake with advanced AI delivering efficiency gains of 30% ✔️ Capture critical safety information while reducing manual effort with Dynamic Data Extraction, enabling faster case intake with 95% accuracy ✔️ Improve consistency and efficiency with AI Narrative Generation, achieving a 90% narrative similarity score ✔️ Optimize field case reporting with ReporterX and the latest NavaX Companion Agent, delivering 65% efficiency gains through advanced AI ✔️ Accelerate signal and risk management with Signal Agents, delivering context-aware insights and decision support in minutes rather than hours Secure your spot: https://lnkd.in/gzHAUu4Z (138 words, 2016-05-18) - [Whitepaper: Solving Data Management Problems through Unified Solutions | ArisGlobal](/content/uncategorized/solving-data-management-problems-through-unified-solutions.html): Slow and costly study builds continue to be a headache, even in the most modern electronic data capture (EDC) platforms. This whitepaper examines the reasons for these problems and how a unified solution can help to meet client deliverables on time, “Slow and costly study builds continue to be a headache, even in the most modern electronic data capture (EDC) platforms. This is for many reasons, such as the need for expert programmers, building in the back end without instant visibility of forms and edit check outputs, inefficient spec, build, review processes, and lengthy, Realizing the full potential of AI in pharmacovigilance is about more than just choosing the right technology. Whether you're building, implementing, or scaling your AI strategy in PV, there are 10 critical questions teams should ask when evaluating AI-enabled technology partners. From assessing controls and outsights to understanding how architecture can scale to support enterprise deployment over time, you will find these 10 questions (and much more) in our newest guide, the AI Integration Roadmap for Pharmacovigilance. Download it now to dive in: https://lnkd.in/gqDU7sGb , On October 1st, join industry peers and learn how dozens of leading life sciences organizations are moving beyond individual use cases in PV workflows toward a fully AI-powered PV operations model delivering tangible results. During this session, we’ll explore how NavaX AI-powered capabilities are already helping organizations: ✔️ Accelerate case intake with advanced AI delivering efficiency gains of 30% ✔️ Capture critical safety information while reducing manual effort with Dynamic Data Extraction, enabling faster case intake with 95% accuracy ✔️ Improve consistency and efficiency with AI Narrative Generation, achieving a 90% narrative similarity score ✔️ Optimize field case reporting with ReporterX and the latest NavaX Companion Agent, delivering 65% efficiency gains through advanced AI ✔️ Accelerate signal and risk management with Signal Agents, delivering context-aware insights and decision support in minutes rather than hours Secure your spot: https://lnkd.in/gzHAUu4Z (212 words, 2016-05-17) - [Whitepaper: Realizing the Promise of EDC: Deriving Greater Value Through its Optimized Use | ArisGlobal](/content/uncategorized/realizing-the-promise-of-edc-deriving-greater-value-through-its-optimized-use.html): The clinical development industry is entering a new era of change and opportunity. It faces an increasing array of drivers from the commercial, regulatory, safety and patient sectors, the likes of which have never been seen before. Download this whitepaper to learn how new generation EDC solution can overcome challenges, “The clinical development industry is entering a new era of change and opportunity. It faces an increasing array of drivers from the commercial, regulatory, safety and patient sectors, the likes of which have never been seen before. In response to these pressures, the industry is embracing new techniques and technologies; electronic data capture, Realizing the full potential of AI in pharmacovigilance is about more than just choosing the right technology. Whether you're building, implementing, or scaling your AI strategy in PV, there are 10 critical questions teams should ask when evaluating AI-enabled technology partners. From assessing controls and outsights to understanding how architecture can scale to support enterprise deployment over time, you will find these 10 questions (and much more) in our newest guide, the AI Integration Roadmap for Pharmacovigilance. Download it now to dive in: https://lnkd.in/gqDU7sGb , On October 1st, join industry peers and learn how dozens of leading life sciences organizations are moving beyond individual use cases in PV workflows toward a fully AI-powered PV operations model delivering tangible results. During this session, we’ll explore how NavaX AI-powered capabilities are already helping organizations: ✔️ Accelerate case intake with advanced AI delivering efficiency gains of 30% ✔️ Capture critical safety information while reducing manual effort with Dynamic Data Extraction, enabling faster case intake with 95% accuracy ✔️ Improve consistency and efficiency with AI Narrative Generation, achieving a 90% narrative similarity score ✔️ Optimize field case reporting with ReporterX and the latest NavaX Companion Agent, delivering 65% efficiency gains through advanced AI ✔️ Accelerate signal and risk management with Signal Agents, delivering context-aware insights and decision support in minutes rather than hours Secure your spot: https://lnkd.in/gzHAUu4Z (339 words, 2016-05-17) - [Whitepaper: Emerging Trends in Electronic Data Capture | ArisGlobal](/content/uncategorized/emerging-trends-in-electronic-data-capture/index.html): Data management has come a long way since using paper in the 1990s. There are still potential limitations to EDC which require further research, such as data security, connectivity, and the need for field staff being comfortable using the technology. Download this whitepaper to learn about the emerging trends in clinical development that are looking to better utilize the latest technology, Data management has come a long way since using paper in the 1990s. Although not all studies have adopted electronic solutions yet, with the exponential increase in technology development and use, growth of the clinical research industry and a market in emerging countries, many clinical research organizations (CROs) are using electronic data capture, Realizing the full potential of AI in pharmacovigilance is about more than just choosing the right technology. Whether you're building, implementing, or scaling your AI strategy in PV, there are 10 critical questions teams should ask when evaluating AI-enabled technology partners. From assessing controls and outsights to understanding how architecture can scale to support enterprise deployment over time, you will find these 10 questions (and much more) in our newest guide, the AI Integration Roadmap for Pharmacovigilance. Download it now to dive in: https://lnkd.in/gqDU7sGb , On October 1st, join industry peers and learn how dozens of leading life sciences organizations are moving beyond individual use cases in PV workflows toward a fully AI-powered PV operations model delivering tangible results. During this session, we’ll explore how NavaX AI-powered capabilities are already helping organizations: ✔️ Accelerate case intake with advanced AI delivering efficiency gains of 30% ✔️ Capture critical safety information while reducing manual effort with Dynamic Data Extraction, enabling faster case intake with 95% accuracy ✔️ Improve consistency and efficiency with AI Narrative Generation, achieving a 90% narrative similarity score ✔️ Optimize field case reporting with ReporterX and the latest NavaX Companion Agent, delivering 65% efficiency gains through advanced AI ✔️ Accelerate signal and risk management with Signal Agents, delivering context-aware insights and decision support in minutes rather than hours Secure your spot: https://lnkd.in/gzHAUu4Z (291 words, 2016-05-17) - [ArisGlobal Expands its Safety Leadership Team with Industry Expertise | ArisGlobal](/content/media/press-release/arisglobal-expands-its-safety-leadership-team-with-industry-expertise.html): Dr. Vivek Ahuja, George Phillips and Stephen Schmidt Join the Growing OrganizationAPRIL 28, 2016 — ArisGlobal®, a leading provider of cloud-based software solutions for life sciences, today announced key new leaders have joined the Safety and Pharmacovigilance team to bring a wealth of insight to a growing business.  This will bolster the company’s safety, Realizing the full potential of AI in pharmacovigilance is about more than just choosing the right technology. Whether you're building, implementing, or scaling your AI strategy in PV, there are 10 critical questions teams should ask when evaluating AI-enabled technology partners. From assessing controls and outsights to understanding how architecture can scale to support enterprise deployment over time, you will find these 10 questions (and much more) in our newest guide, the AI Integration Roadmap for Pharmacovigilance. Download it now to dive in: https://lnkd.in/gqDU7sGb , On October 1st, join industry peers and learn how dozens of leading life sciences organizations are moving beyond individual use cases in PV workflows toward a fully AI-powered PV operations model delivering tangible results. During this session, we’ll explore how NavaX AI-powered capabilities are already helping organizations: ✔️ Accelerate case intake with advanced AI delivering efficiency gains of 30% ✔️ Capture critical safety information while reducing manual effort with Dynamic Data Extraction, enabling faster case intake with 95% accuracy ✔️ Improve consistency and efficiency with AI Narrative Generation, achieving a 90% narrative similarity score ✔️ Optimize field case reporting with ReporterX and the latest NavaX Companion Agent, delivering 65% efficiency gains through advanced AI ✔️ Accelerate signal and risk management with Signal Agents, delivering context-aware insights and decision support in minutes rather than hours Secure your spot: https://lnkd.in/gzHAUu4Z (390 words, 2016-05-02) - [Press Release: ArisGlobal announces record growth in 2015 | ArisGlobal](/content/media/press-release/arisglobal-announces-record-growth-in-2015/index.html): ArisGlobal, a leading provider of cloud-based software solutions for life sciences, announced it achieved record growth in 2015. Read here, CHICAGO, IL.  APRIL 10th, 2016: ArisGlobal®, a leading provider of cloud-based software solutions for life sciences, today announced it achieved record growth, market expansion, and major product innovations in 2015. The company has robust plans in place to continually innovate its life sciences cloud platform for regulatory compliance and drug development.With an extended client community, Realizing the full potential of AI in pharmacovigilance is about more than just choosing the right technology. Whether you're building, implementing, or scaling your AI strategy in PV, there are 10 critical questions teams should ask when evaluating AI-enabled technology partners. From assessing controls and outsights to understanding how architecture can scale to support enterprise deployment over time, you will find these 10 questions (and much more) in our newest guide, the AI Integration Roadmap for Pharmacovigilance. Download it now to dive in: https://lnkd.in/gqDU7sGb , On October 1st, join industry peers and learn how dozens of leading life sciences organizations are moving beyond individual use cases in PV workflows toward a fully AI-powered PV operations model delivering tangible results. During this session, we’ll explore how NavaX AI-powered capabilities are already helping organizations: ✔️ Accelerate case intake with advanced AI delivering efficiency gains of 30% ✔️ Capture critical safety information while reducing manual effort with Dynamic Data Extraction, enabling faster case intake with 95% accuracy ✔️ Improve consistency and efficiency with AI Narrative Generation, achieving a 90% narrative similarity score ✔️ Optimize field case reporting with ReporterX and the latest NavaX Companion Agent, delivering 65% efficiency gains through advanced AI ✔️ Accelerate signal and risk management with Signal Agents, delivering context-aware insights and decision support in minutes rather than hours Secure your spot: https://lnkd.in/gzHAUu4Z (385 words, 2016-05-02) - [Whitepaper: Intelligent Monitoring in Clinical Trials | ArisGlobal](/content/uncategorized/intelligent-monitoring-in-clinical-trials/index.html): One of today’s big conversations in clinical research is how the conventional approach for monitoring trial conduct simply doesn’t give the best view of data. Download this whitepaper which describes the various types of risks involved and the importance of a framework that combines optimal monitoring strategies, One of today’s big conversations in clinical research is how the conventional approach for monitoring trial conduct simply doesn’t give the best view of data to protect patient safety, comply with protocol procedures and ensure the accuracy of data collected during the conduct of a study. This conventional approach, involving periodic site visits, Realizing the full potential of AI in pharmacovigilance is about more than just choosing the right technology. Whether you're building, implementing, or scaling your AI strategy in PV, there are 10 critical questions teams should ask when evaluating AI-enabled technology partners. From assessing controls and outsights to understanding how architecture can scale to support enterprise deployment over time, you will find these 10 questions (and much more) in our newest guide, the AI Integration Roadmap for Pharmacovigilance. Download it now to dive in: https://lnkd.in/gqDU7sGb , On October 1st, join industry peers and learn how dozens of leading life sciences organizations are moving beyond individual use cases in PV workflows toward a fully AI-powered PV operations model delivering tangible results. During this session, we’ll explore how NavaX AI-powered capabilities are already helping organizations: ✔️ Accelerate case intake with advanced AI delivering efficiency gains of 30% ✔️ Capture critical safety information while reducing manual effort with Dynamic Data Extraction, enabling faster case intake with 95% accuracy ✔️ Improve consistency and efficiency with AI Narrative Generation, achieving a 90% narrative similarity score ✔️ Optimize field case reporting with ReporterX and the latest NavaX Companion Agent, delivering 65% efficiency gains through advanced AI ✔️ Accelerate signal and risk management with Signal Agents, delivering context-aware insights and decision support in minutes rather than hours Secure your spot: https://lnkd.in/gzHAUu4Z (198 words, 2016-04-14) - [Investigator Portals: Facilitating and Streamlining Communications & Collaboration with Study Sites | ArisGlobal](/content/uncategorized/investigator-portals-facilitating-and-streamlining-communications-collaboration-with-study-sites.html): The reality is that investigator site personnel are often frustrated with the lack of transparency and communication with their sponsors, leading to significant dissatisfaction and often withdrawal from current and future studies. The adoption of investigator portals gives sponsors a platform that fosters collaboration and improves site management.This white paper explores in detail five key, Realizing the full potential of AI in pharmacovigilance is about more than just choosing the right technology. Whether you're building, implementing, or scaling your AI strategy in PV, there are 10 critical questions teams should ask when evaluating AI-enabled technology partners. From assessing controls and outsights to understanding how architecture can scale to support enterprise deployment over time, you will find these 10 questions (and much more) in our newest guide, the AI Integration Roadmap for Pharmacovigilance. Download it now to dive in: https://lnkd.in/gqDU7sGb , On October 1st, join industry peers and learn how dozens of leading life sciences organizations are moving beyond individual use cases in PV workflows toward a fully AI-powered PV operations model delivering tangible results. During this session, we’ll explore how NavaX AI-powered capabilities are already helping organizations: ✔️ Accelerate case intake with advanced AI delivering efficiency gains of 30% ✔️ Capture critical safety information while reducing manual effort with Dynamic Data Extraction, enabling faster case intake with 95% accuracy ✔️ Improve consistency and efficiency with AI Narrative Generation, achieving a 90% narrative similarity score ✔️ Optimize field case reporting with ReporterX and the latest NavaX Companion Agent, delivering 65% efficiency gains through advanced AI ✔️ Accelerate signal and risk management with Signal Agents, delivering context-aware insights and decision support in minutes rather than hours Secure your spot: https://lnkd.in/gzHAUu4Z (220 words, 2016-04-14) - [Press Release: ArisGlobal Pharmacovigilance Software at Merck KGaA](/content/media/press-release/arisglobal-software-and-technologies-enhance-pharmacovigilance-compliance-and-efficiency-at-merck-kgaa.html): ArisGlobal's pharmacovigilance software and technologies enhances pharmacovigilance compliance and efficiency at Merck KGaA. Read here, ArisGlobal continues to support Merck KGaA, the biopharmaceutical business of Merck KGaA, Darmstadt, Germany, in providing software and technology upgrades that further enhance pharmacovigilance compliance and efficiency. These upgrades reflect the commitment of Merck Serono to patient safety as a core priority.Recently, Merck KGaA launched ArisGlobal’s E2B(R3) compliant solution and safety software suite, moving from, Realizing the full potential of AI in pharmacovigilance is about more than just choosing the right technology. Whether you're building, implementing, or scaling your AI strategy in PV, there are 10 critical questions teams should ask when evaluating AI-enabled technology partners. From assessing controls and outsights to understanding how architecture can scale to support enterprise deployment over time, you will find these 10 questions (and much more) in our newest guide, the AI Integration Roadmap for Pharmacovigilance. Download it now to dive in: https://lnkd.in/gqDU7sGb , On October 1st, join industry peers and learn how dozens of leading life sciences organizations are moving beyond individual use cases in PV workflows toward a fully AI-powered PV operations model delivering tangible results. During this session, we’ll explore how NavaX AI-powered capabilities are already helping organizations: ✔️ Accelerate case intake with advanced AI delivering efficiency gains of 30% ✔️ Capture critical safety information while reducing manual effort with Dynamic Data Extraction, enabling faster case intake with 95% accuracy ✔️ Improve consistency and efficiency with AI Narrative Generation, achieving a 90% narrative similarity score ✔️ Optimize field case reporting with ReporterX and the latest NavaX Companion Agent, delivering 65% efficiency gains through advanced AI ✔️ Accelerate signal and risk management with Signal Agents, delivering context-aware insights and decision support in minutes rather than hours Secure your spot: https://lnkd.in/gzHAUu4Z (451 words, 2016-04-06) - [CRO Partners with ArisGlobal to Manage Clinical Trials | ArisGlobal](/content/blogs/cro-partners-arisglobal-manage-clinical-trial/index.html): CUSTOMER BACKGROUNDA full service contract research organization (CRO) specialized in outsourced early drug development and late phase services. They provide regulatory, data management and project management to both domestic and worldwide companies in the pharmaceutical, medical device and biotechnology industries.LIFE BEFORE CHOOSING A SOLUTIONIn the past, they struggled with a decentralized project management, Realizing the full potential of AI in pharmacovigilance is about more than just choosing the right technology. Whether you're building, implementing, or scaling your AI strategy in PV, there are 10 critical questions teams should ask when evaluating AI-enabled technology partners. From assessing controls and outsights to understanding how architecture can scale to support enterprise deployment over time, you will find these 10 questions (and much more) in our newest guide, the AI Integration Roadmap for Pharmacovigilance. Download it now to dive in: https://lnkd.in/gqDU7sGb , On October 1st, join industry peers and learn how dozens of leading life sciences organizations are moving beyond individual use cases in PV workflows toward a fully AI-powered PV operations model delivering tangible results. During this session, we’ll explore how NavaX AI-powered capabilities are already helping organizations: ✔️ Accelerate case intake with advanced AI delivering efficiency gains of 30% ✔️ Capture critical safety information while reducing manual effort with Dynamic Data Extraction, enabling faster case intake with 95% accuracy ✔️ Improve consistency and efficiency with AI Narrative Generation, achieving a 90% narrative similarity score ✔️ Optimize field case reporting with ReporterX and the latest NavaX Companion Agent, delivering 65% efficiency gains through advanced AI ✔️ Accelerate signal and risk management with Signal Agents, delivering context-aware insights and decision support in minutes rather than hours Secure your spot: https://lnkd.in/gzHAUu4Z (289 words, 2016-04-05) - [What is Really Required in a Modern EDC? | ArisGlobal](/content/blogs/what-is-really-required-in-a-modern-edc/index.html): Electronic data capture (EDC) system benefits from technology advancements and evolving standards. Read the Blog., I wrote a post a couple of months ago about the drawbacks of accessing multiple data sources. I discussed how it was essential for project managers to have the available technology, designed for usability that enables them to have the necessary visibility, Realizing the full potential of AI in pharmacovigilance is about more than just choosing the right technology. Whether you're building, implementing, or scaling your AI strategy in PV, there are 10 critical questions teams should ask when evaluating AI-enabled technology partners. From assessing controls and outsights to understanding how architecture can scale to support enterprise deployment over time, you will find these 10 questions (and much more) in our newest guide, the AI Integration Roadmap for Pharmacovigilance. Download it now to dive in: https://lnkd.in/gqDU7sGb , On October 1st, join industry peers and learn how dozens of leading life sciences organizations are moving beyond individual use cases in PV workflows toward a fully AI-powered PV operations model delivering tangible results. During this session, we’ll explore how NavaX AI-powered capabilities are already helping organizations: ✔️ Accelerate case intake with advanced AI delivering efficiency gains of 30% ✔️ Capture critical safety information while reducing manual effort with Dynamic Data Extraction, enabling faster case intake with 95% accuracy ✔️ Improve consistency and efficiency with AI Narrative Generation, achieving a 90% narrative similarity score ✔️ Optimize field case reporting with ReporterX and the latest NavaX Companion Agent, delivering 65% efficiency gains through advanced AI ✔️ Accelerate signal and risk management with Signal Agents, delivering context-aware insights and decision support in minutes rather than hours Secure your spot: https://lnkd.in/gzHAUu4Z (530 words, 2016-04-05) - [Five Key Steps You Need For Trial Disclosure | ArisGlobal](/content/blogs/five-key-steps-you-need-for-trial-disclosure/index.html): For an efficient and high-quality process, learn the five key steps you need to know for clinical trial disclosure. Read the Blog., Post by Mathias PoensgenFirst, it was mandatory to submit results to ClinicalTrials.gov. Then, from July 2014, it also became mandatory for companies to report their results to EudraCT. Combine this with the requirement of companies needing to submit to additional registries, we can see why trial, Realizing the full potential of AI in pharmacovigilance is about more than just choosing the right technology. Whether you're building, implementing, or scaling your AI strategy in PV, there are 10 critical questions teams should ask when evaluating AI-enabled technology partners. From assessing controls and outsights to understanding how architecture can scale to support enterprise deployment over time, you will find these 10 questions (and much more) in our newest guide, the AI Integration Roadmap for Pharmacovigilance. Download it now to dive in: https://lnkd.in/gqDU7sGb , On October 1st, join industry peers and learn how dozens of leading life sciences organizations are moving beyond individual use cases in PV workflows toward a fully AI-powered PV operations model delivering tangible results. During this session, we’ll explore how NavaX AI-powered capabilities are already helping organizations: ✔️ Accelerate case intake with advanced AI delivering efficiency gains of 30% ✔️ Capture critical safety information while reducing manual effort with Dynamic Data Extraction, enabling faster case intake with 95% accuracy ✔️ Improve consistency and efficiency with AI Narrative Generation, achieving a 90% narrative similarity score ✔️ Optimize field case reporting with ReporterX and the latest NavaX Companion Agent, delivering 65% efficiency gains through advanced AI ✔️ Accelerate signal and risk management with Signal Agents, delivering context-aware insights and decision support in minutes rather than hours Secure your spot: https://lnkd.in/gzHAUu4Z (821 words, 2016-04-05) - [ArisGlobal’s Collaborative Approach Helps Global Pharma Track Registrations | ArisGlobal](/content/uncategorized/arisglobals-collaborative-approach-helps-global-pharma-track-registrations.html): Customer BackgroundThis European international pharmaceutical company engages in the research and development, production, marketing, and sale of drugs for the treatment of diseases of the nervous system. The customer has international production facilities in Europe and South America and affiliates or sales offices in more than 50 countries. It employs over 5000 people globally and, Realizing the full potential of AI in pharmacovigilance is about more than just choosing the right technology. Whether you're building, implementing, or scaling your AI strategy in PV, there are 10 critical questions teams should ask when evaluating AI-enabled technology partners. From assessing controls and outsights to understanding how architecture can scale to support enterprise deployment over time, you will find these 10 questions (and much more) in our newest guide, the AI Integration Roadmap for Pharmacovigilance. Download it now to dive in: https://lnkd.in/gqDU7sGb , On October 1st, join industry peers and learn how dozens of leading life sciences organizations are moving beyond individual use cases in PV workflows toward a fully AI-powered PV operations model delivering tangible results. During this session, we’ll explore how NavaX AI-powered capabilities are already helping organizations: ✔️ Accelerate case intake with advanced AI delivering efficiency gains of 30% ✔️ Capture critical safety information while reducing manual effort with Dynamic Data Extraction, enabling faster case intake with 95% accuracy ✔️ Improve consistency and efficiency with AI Narrative Generation, achieving a 90% narrative similarity score ✔️ Optimize field case reporting with ReporterX and the latest NavaX Companion Agent, delivering 65% efficiency gains through advanced AI ✔️ Accelerate signal and risk management with Signal Agents, delivering context-aware insights and decision support in minutes rather than hours Secure your spot: https://lnkd.in/gzHAUu4Z (718 words, 2016-04-05) - [Case Study: How Register Enables Compliance and Tracking for Post-Merger Global Pharma | ArisGlobal](/content/uncategorized/register-enables-compliance-tracking-post-merger-global-pharma.html): A global pharma organization headquartered in Asia selected ArisGlobal's Register to achieve its compliance objectives, and gain greater oversight and understanding of products in the market, including the status of individual products in different geographies., Customer BackgroundIn many western countries, healthcare is available and accessible to just about everyone. But in many parts of the world, this is not the case. A global pharma organization headquartered in Asia discovers and produces innovative medicines that create a better future for patients in disease areas where there is a large unfulfilled medical, Realizing the full potential of AI in pharmacovigilance is about more than just choosing the right technology. Whether you're building, implementing, or scaling your AI strategy in PV, there are 10 critical questions teams should ask when evaluating AI-enabled technology partners. From assessing controls and outsights to understanding how architecture can scale to support enterprise deployment over time, you will find these 10 questions (and much more) in our newest guide, the AI Integration Roadmap for Pharmacovigilance. Download it now to dive in: https://lnkd.in/gqDU7sGb , On October 1st, join industry peers and learn how dozens of leading life sciences organizations are moving beyond individual use cases in PV workflows toward a fully AI-powered PV operations model delivering tangible results. During this session, we’ll explore how NavaX AI-powered capabilities are already helping organizations: ✔️ Accelerate case intake with advanced AI delivering efficiency gains of 30% ✔️ Capture critical safety information while reducing manual effort with Dynamic Data Extraction, enabling faster case intake with 95% accuracy ✔️ Improve consistency and efficiency with AI Narrative Generation, achieving a 90% narrative similarity score ✔️ Optimize field case reporting with ReporterX and the latest NavaX Companion Agent, delivering 65% efficiency gains through advanced AI ✔️ Accelerate signal and risk management with Signal Agents, delivering context-aware insights and decision support in minutes rather than hours Secure your spot: https://lnkd.in/gzHAUu4Z (848 words, 2016-04-05) - [The Challenge with Today’s Clinical Analytic Platforms | ArisGlobal](/content/blogs/the-challenge-with-todays-clinical-analytic-platforms.html): Clinical Analytic Platforms is complete solution for clinical organizations. But organizations have challenges implementing it. Read our Blog., In today’s fast paced ‘all or nothing’ innovative solution-focused industry, clinical software repositories and data analytic solutions for data conformance tend to be complex and miles away from empowering the user with flexibility and ease of use. Time after time, users struggle having to manually create programs, tables, and libraries for data conformance,, Realizing the full potential of AI in pharmacovigilance is about more than just choosing the right technology. Whether you're building, implementing, or scaling your AI strategy in PV, there are 10 critical questions teams should ask when evaluating AI-enabled technology partners. From assessing controls and outsights to understanding how architecture can scale to support enterprise deployment over time, you will find these 10 questions (and much more) in our newest guide, the AI Integration Roadmap for Pharmacovigilance. Download it now to dive in: https://lnkd.in/gqDU7sGb , On October 1st, join industry peers and learn how dozens of leading life sciences organizations are moving beyond individual use cases in PV workflows toward a fully AI-powered PV operations model delivering tangible results. During this session, we’ll explore how NavaX AI-powered capabilities are already helping organizations: ✔️ Accelerate case intake with advanced AI delivering efficiency gains of 30% ✔️ Capture critical safety information while reducing manual effort with Dynamic Data Extraction, enabling faster case intake with 95% accuracy ✔️ Improve consistency and efficiency with AI Narrative Generation, achieving a 90% narrative similarity score ✔️ Optimize field case reporting with ReporterX and the latest NavaX Companion Agent, delivering 65% efficiency gains through advanced AI ✔️ Accelerate signal and risk management with Signal Agents, delivering context-aware insights and decision support in minutes rather than hours Secure your spot: https://lnkd.in/gzHAUu4Z (485 words, 2016-04-05) - [Global CRO chooses ArisGlobal to manage Clinical and Pharmacovigilance | ArisGlobal](/content/blogs/global-cro-choose-arisglobal-manage-clinical-pharmacovigilance.html): CUSTOMER BACKGROUNDHeadquartered in the United Kingdom, this CRO is a privately held, international full-service contract research organization to the pharmaceutical and biotech industry. It has grown rapidly since it was founded in 1997 and now serves its clients from its main operational hubs in France, Germany, USA, Italy and Australia, along with supporting, Realizing the full potential of AI in pharmacovigilance is about more than just choosing the right technology. Whether you're building, implementing, or scaling your AI strategy in PV, there are 10 critical questions teams should ask when evaluating AI-enabled technology partners. From assessing controls and outsights to understanding how architecture can scale to support enterprise deployment over time, you will find these 10 questions (and much more) in our newest guide, the AI Integration Roadmap for Pharmacovigilance. Download it now to dive in: https://lnkd.in/gqDU7sGb , On October 1st, join industry peers and learn how dozens of leading life sciences organizations are moving beyond individual use cases in PV workflows toward a fully AI-powered PV operations model delivering tangible results. During this session, we’ll explore how NavaX AI-powered capabilities are already helping organizations: ✔️ Accelerate case intake with advanced AI delivering efficiency gains of 30% ✔️ Capture critical safety information while reducing manual effort with Dynamic Data Extraction, enabling faster case intake with 95% accuracy ✔️ Improve consistency and efficiency with AI Narrative Generation, achieving a 90% narrative similarity score ✔️ Optimize field case reporting with ReporterX and the latest NavaX Companion Agent, delivering 65% efficiency gains through advanced AI ✔️ Accelerate signal and risk management with Signal Agents, delivering context-aware insights and decision support in minutes rather than hours Secure your spot: https://lnkd.in/gzHAUu4Z (1,489 words, 2016-04-05) - [press Release: ArisGlobal signs first ARISj customer in China | ArisGlobal](/content/media/press-release/arisglobal-signs-first-arisg-customer-in-china/index.html): ArisGlobal announced that Chengdu Institute of Biological Products Co., Ltd. (CDIBP) has selected ARISj to strengthen its pharmacovigilance process, Chengdu Institute of Biological Products Co., Ltd. to Strengthens Pharmacovigilance Process using ArisGlobal’s ARISg™ Solution.Princeton, NJ— 21st January, 2016: ArisGlobal®, a leading provider of software solutions to the life science industry, has announced that Chengdu Institute of Biological Products Co., Ltd. (CDIBP) has selected ARISg™ to strengthen and build a solid, Realizing the full potential of AI in pharmacovigilance is about more than just choosing the right technology. Whether you're building, implementing, or scaling your AI strategy in PV, there are 10 critical questions teams should ask when evaluating AI-enabled technology partners. From assessing controls and outsights to understanding how architecture can scale to support enterprise deployment over time, you will find these 10 questions (and much more) in our newest guide, the AI Integration Roadmap for Pharmacovigilance. Download it now to dive in: https://lnkd.in/gqDU7sGb , On October 1st, join industry peers and learn how dozens of leading life sciences organizations are moving beyond individual use cases in PV workflows toward a fully AI-powered PV operations model delivering tangible results. During this session, we’ll explore how NavaX AI-powered capabilities are already helping organizations: ✔️ Accelerate case intake with advanced AI delivering efficiency gains of 30% ✔️ Capture critical safety information while reducing manual effort with Dynamic Data Extraction, enabling faster case intake with 95% accuracy ✔️ Improve consistency and efficiency with AI Narrative Generation, achieving a 90% narrative similarity score ✔️ Optimize field case reporting with ReporterX and the latest NavaX Companion Agent, delivering 65% efficiency gains through advanced AI ✔️ Accelerate signal and risk management with Signal Agents, delivering context-aware insights and decision support in minutes rather than hours Secure your spot: https://lnkd.in/gzHAUu4Z (425 words, 2016-03-07) - [Trial Disclosure - Regulatory Updates & FAQs | ArisGlobal](/content/blogs/trial-disclosure-regulatory-updates-faqs/index.html): The requirements for data disclosure in clinical trials are continuously evolving. Although the purpose is to ultimately make data transparency greater, the constant updates can make it hard to understand what the current regulations are and what are coming up. This leads to many questions, including what data submissions, Realizing the full potential of AI in pharmacovigilance is about more than just choosing the right technology. Whether you're building, implementing, or scaling your AI strategy in PV, there are 10 critical questions teams should ask when evaluating AI-enabled technology partners. From assessing controls and outsights to understanding how architecture can scale to support enterprise deployment over time, you will find these 10 questions (and much more) in our newest guide, the AI Integration Roadmap for Pharmacovigilance. Download it now to dive in: https://lnkd.in/gqDU7sGb , On October 1st, join industry peers and learn how dozens of leading life sciences organizations are moving beyond individual use cases in PV workflows toward a fully AI-powered PV operations model delivering tangible results. During this session, we’ll explore how NavaX AI-powered capabilities are already helping organizations: ✔️ Accelerate case intake with advanced AI delivering efficiency gains of 30% ✔️ Capture critical safety information while reducing manual effort with Dynamic Data Extraction, enabling faster case intake with 95% accuracy ✔️ Improve consistency and efficiency with AI Narrative Generation, achieving a 90% narrative similarity score ✔️ Optimize field case reporting with ReporterX and the latest NavaX Companion Agent, delivering 65% efficiency gains through advanced AI ✔️ Accelerate signal and risk management with Signal Agents, delivering context-aware insights and decision support in minutes rather than hours Secure your spot: https://lnkd.in/gzHAUu4Z (179 words, 2016-03-05) - [Achieving Successful Business Outcomes Through a Flexible EDC Platform | ArisGlobal](/content/blogs/achieving-successful-business-outcomes-through-a-flexible-edc-platform.html): Watch to gain insight into what is required from a platform to provide this level of flexibility, and the benefits this entails. Watch this 45-minute on-demand webinar to learn about key EDC attributes, including: Integration with different clients' systems Unified solution offering EDC along with eCOA, Randomization and Trial Supply Management Consideration for eSource, medical, Realizing the full potential of AI in pharmacovigilance is about more than just choosing the right technology. Whether you're building, implementing, or scaling your AI strategy in PV, there are 10 critical questions teams should ask when evaluating AI-enabled technology partners. From assessing controls and outsights to understanding how architecture can scale to support enterprise deployment over time, you will find these 10 questions (and much more) in our newest guide, the AI Integration Roadmap for Pharmacovigilance. Download it now to dive in: https://lnkd.in/gqDU7sGb , On October 1st, join industry peers and learn how dozens of leading life sciences organizations are moving beyond individual use cases in PV workflows toward a fully AI-powered PV operations model delivering tangible results. During this session, we’ll explore how NavaX AI-powered capabilities are already helping organizations: ✔️ Accelerate case intake with advanced AI delivering efficiency gains of 30% ✔️ Capture critical safety information while reducing manual effort with Dynamic Data Extraction, enabling faster case intake with 95% accuracy ✔️ Improve consistency and efficiency with AI Narrative Generation, achieving a 90% narrative similarity score ✔️ Optimize field case reporting with ReporterX and the latest NavaX Companion Agent, delivering 65% efficiency gains through advanced AI ✔️ Accelerate signal and risk management with Signal Agents, delivering context-aware insights and decision support in minutes rather than hours Secure your spot: https://lnkd.in/gzHAUu4Z (200 words, 2016-03-05) - [agInquirer | ArisGlobal](/content/uncategorized/aginquirer/index.html): agInquirer, Realizing the full potential of AI in pharmacovigilance is about more than just choosing the right technology. Whether you're building, implementing, or scaling your AI strategy in PV, there are 10 critical questions teams should ask when evaluating AI-enabled technology partners. From assessing controls and outsights to understanding how architecture can scale to support enterprise deployment over time, you will find these 10 questions (and much more) in our newest guide, the AI Integration Roadmap for Pharmacovigilance. Download it now to dive in: https://lnkd.in/gqDU7sGb , On October 1st, join industry peers and learn how dozens of leading life sciences organizations are moving beyond individual use cases in PV workflows toward a fully AI-powered PV operations model delivering tangible results. During this session, we’ll explore how NavaX AI-powered capabilities are already helping organizations: ✔️ Accelerate case intake with advanced AI delivering efficiency gains of 30% ✔️ Capture critical safety information while reducing manual effort with Dynamic Data Extraction, enabling faster case intake with 95% accuracy ✔️ Improve consistency and efficiency with AI Narrative Generation, achieving a 90% narrative similarity score ✔️ Optimize field case reporting with ReporterX and the latest NavaX Companion Agent, delivering 65% efficiency gains through advanced AI ✔️ Accelerate signal and risk management with Signal Agents, delivering context-aware insights and decision support in minutes rather than hours Secure your spot: https://lnkd.in/gzHAUu4Z (137 words, 2016-03-04) - [Empowering Global Medical Information Teams | White Paper | ArisGlobal](/content/uncategorized/empowering-global-medical-information-teams-with-software-solutions-white-paper.html): This whitepaper discusses the attributes of high performing medical information (MI) teams operating in a global environment and discusses in detail the expertise, processes and tools required to increase the performance and value delivered by a truly global MI team., This whitepaper discusses the attributes of high performing medical information (MI) teams operating in a global environment and discusses in detail the expertise, processes and tools required to increase the performance and value delivered by a truly global MI team. This paper further compares the key types of medical information strategies and software, Realizing the full potential of AI in pharmacovigilance is about more than just choosing the right technology. Whether you're building, implementing, or scaling your AI strategy in PV, there are 10 critical questions teams should ask when evaluating AI-enabled technology partners. From assessing controls and outsights to understanding how architecture can scale to support enterprise deployment over time, you will find these 10 questions (and much more) in our newest guide, the AI Integration Roadmap for Pharmacovigilance. Download it now to dive in: https://lnkd.in/gqDU7sGb , On October 1st, join industry peers and learn how dozens of leading life sciences organizations are moving beyond individual use cases in PV workflows toward a fully AI-powered PV operations model delivering tangible results. During this session, we’ll explore how NavaX AI-powered capabilities are already helping organizations: ✔️ Accelerate case intake with advanced AI delivering efficiency gains of 30% ✔️ Capture critical safety information while reducing manual effort with Dynamic Data Extraction, enabling faster case intake with 95% accuracy ✔️ Improve consistency and efficiency with AI Narrative Generation, achieving a 90% narrative similarity score ✔️ Optimize field case reporting with ReporterX and the latest NavaX Companion Agent, delivering 65% efficiency gains through advanced AI ✔️ Accelerate signal and risk management with Signal Agents, delivering context-aware insights and decision support in minutes rather than hours Secure your spot: https://lnkd.in/gzHAUu4Z (235 words, 2016-03-04) - [Whitepaper: Medical Information Role in Pharmaceutical Industry | ArisGlobal](/content/uncategorized/medical-information-role-in-pharmaceutical-industry-white-paper.html): Medical information (MI) teams at pharmaceutical and medical device companies primarily respond to inquiries about the company’s products. This whitepaper details the medical information function, role and workflow to which often underestimated and overlooked, This white paper details the MI function, roles, workflow, tools and related topics to give you an inside look at this critical but often overlooked and underestimated department. Whether a global pharma, emerging bio-tech, CRO, aspiring PharmD, or just an interested party, we believe you’ll get value from this new white paper.Know More:, Realizing the full potential of AI in pharmacovigilance is about more than just choosing the right technology. Whether you're building, implementing, or scaling your AI strategy in PV, there are 10 critical questions teams should ask when evaluating AI-enabled technology partners. From assessing controls and outsights to understanding how architecture can scale to support enterprise deployment over time, you will find these 10 questions (and much more) in our newest guide, the AI Integration Roadmap for Pharmacovigilance. Download it now to dive in: https://lnkd.in/gqDU7sGb , On October 1st, join industry peers and learn how dozens of leading life sciences organizations are moving beyond individual use cases in PV workflows toward a fully AI-powered PV operations model delivering tangible results. During this session, we’ll explore how NavaX AI-powered capabilities are already helping organizations: ✔️ Accelerate case intake with advanced AI delivering efficiency gains of 30% ✔️ Capture critical safety information while reducing manual effort with Dynamic Data Extraction, enabling faster case intake with 95% accuracy ✔️ Improve consistency and efficiency with AI Narrative Generation, achieving a 90% narrative similarity score ✔️ Optimize field case reporting with ReporterX and the latest NavaX Companion Agent, delivering 65% efficiency gains through advanced AI ✔️ Accelerate signal and risk management with Signal Agents, delivering context-aware insights and decision support in minutes rather than hours Secure your spot: https://lnkd.in/gzHAUu4Z (137 words, 2016-03-04) - [Register™ | ArisGlobal](/content/uncategorized/register/index.html): ArisGlobal's LifeSphere clinical and regulatory product leader will host a workshop and virtual discussion on TMF health.NEW ORLEANS, LA - Sondra Pepe, Associate Vice President, Clinical and Regulatory Product Management, ArisGlobal, will provide insights and perspective at the tenth annual TMF Summit, a renowned event for top-tier discussions around eTMF innovations, integrated technology, and, Realizing the full potential of AI in pharmacovigilance is about more than just choosing the right technology. Whether you're building, implementing, or scaling your AI strategy in PV, there are 10 critical questions teams should ask when evaluating AI-enabled technology partners. From assessing controls and outsights to understanding how architecture can scale to support enterprise deployment over time, you will find these 10 questions (and much more) in our newest guide, the AI Integration Roadmap for Pharmacovigilance. Download it now to dive in: https://lnkd.in/gqDU7sGb , On October 1st, join industry peers and learn how dozens of leading life sciences organizations are moving beyond individual use cases in PV workflows toward a fully AI-powered PV operations model delivering tangible results. During this session, we’ll explore how NavaX AI-powered capabilities are already helping organizations: ✔️ Accelerate case intake with advanced AI delivering efficiency gains of 30% ✔️ Capture critical safety information while reducing manual effort with Dynamic Data Extraction, enabling faster case intake with 95% accuracy ✔️ Improve consistency and efficiency with AI Narrative Generation, achieving a 90% narrative similarity score ✔️ Optimize field case reporting with ReporterX and the latest NavaX Companion Agent, delivering 65% efficiency gains through advanced AI ✔️ Accelerate signal and risk management with Signal Agents, delivering context-aware insights and decision support in minutes rather than hours Secure your spot: https://lnkd.in/gzHAUu4Z (481 words, 2016-03-04) - [ARISg and ARISj: Extending a Worldwide Pharmacovigilance Program into the Japanese Market - White paper | ArisGlobal](/content/uncategorized/arisg-and-arisj-extending-a-worldwide-pharmacovigilance-program-into-the-japanese-market-white-paper.html): An integrated safety and pharmacovigilance system with worldwide business processes helps companies realize significant productivity benefits. This position paper summarizes Aris Global’s Total Safety global solution for companies that are either headquartered in Japan or have Japanese affiliates and focuses on the key benefits of deploying a single safety and pharmacovigilance system., Realizing the full potential of AI in pharmacovigilance is about more than just choosing the right technology. Whether you're building, implementing, or scaling your AI strategy in PV, there are 10 critical questions teams should ask when evaluating AI-enabled technology partners. From assessing controls and outsights to understanding how architecture can scale to support enterprise deployment over time, you will find these 10 questions (and much more) in our newest guide, the AI Integration Roadmap for Pharmacovigilance. Download it now to dive in: https://lnkd.in/gqDU7sGb , On October 1st, join industry peers and learn how dozens of leading life sciences organizations are moving beyond individual use cases in PV workflows toward a fully AI-powered PV operations model delivering tangible results. During this session, we’ll explore how NavaX AI-powered capabilities are already helping organizations: ✔️ Accelerate case intake with advanced AI delivering efficiency gains of 30% ✔️ Capture critical safety information while reducing manual effort with Dynamic Data Extraction, enabling faster case intake with 95% accuracy ✔️ Improve consistency and efficiency with AI Narrative Generation, achieving a 90% narrative similarity score ✔️ Optimize field case reporting with ReporterX and the latest NavaX Companion Agent, delivering 65% efficiency gains through advanced AI ✔️ Accelerate signal and risk management with Signal Agents, delivering context-aware insights and decision support in minutes rather than hours Secure your spot: https://lnkd.in/gzHAUu4Z (242 words, 2016-03-04) - [On-Demand Webinar: Cosmetovigilance – Regulatory requirements & compliance through LifeSphere Safety MultiVigilance (ARISg) | ArisGlobal](/content/uncategorized/on-demand-webinar-cosmetovigilance-regulatory-requirements-compliance-through-arisg.html): With an increased focus on cosmetovigilance driven by regulatory agencies across countries, the safety departments need to understand the impact of these regulations, the general cosmetovigilance process and ensure compliance. Under the new EU Regulation (EC) No 1223/2009, cosmetic companies are required to have information clearly available to the Regulatory Authorities concerning their, Realizing the full potential of AI in pharmacovigilance is about more than just choosing the right technology. Whether you're building, implementing, or scaling your AI strategy in PV, there are 10 critical questions teams should ask when evaluating AI-enabled technology partners. From assessing controls and outsights to understanding how architecture can scale to support enterprise deployment over time, you will find these 10 questions (and much more) in our newest guide, the AI Integration Roadmap for Pharmacovigilance. Download it now to dive in: https://lnkd.in/gqDU7sGb , On October 1st, join industry peers and learn how dozens of leading life sciences organizations are moving beyond individual use cases in PV workflows toward a fully AI-powered PV operations model delivering tangible results. During this session, we’ll explore how NavaX AI-powered capabilities are already helping organizations: ✔️ Accelerate case intake with advanced AI delivering efficiency gains of 30% ✔️ Capture critical safety information while reducing manual effort with Dynamic Data Extraction, enabling faster case intake with 95% accuracy ✔️ Improve consistency and efficiency with AI Narrative Generation, achieving a 90% narrative similarity score ✔️ Optimize field case reporting with ReporterX and the latest NavaX Companion Agent, delivering 65% efficiency gains through advanced AI ✔️ Accelerate signal and risk management with Signal Agents, delivering context-aware insights and decision support in minutes rather than hours Secure your spot: https://lnkd.in/gzHAUu4Z (333 words, 2016-02-29) - [ARISGLOBAL RELOCATES TO BETTER SERVE CUSTOMERS WITH ITS TOTAL LIFE CYCLE SOLUTION | ArisGlobal](/content/media/press-release/arisglobal-relocates-to-better-serve-customers-with-its-total-life-cycle-solution.html): To further support its customers as they adopt and leverage its software solutions from the conception to commercialization of their products, ArisGlobal announces that it has relocated its offices to three key cities across the U.S.After over 20 years in Stamford, CT corporate headquarters are, Realizing the full potential of AI in pharmacovigilance is about more than just choosing the right technology. Whether you're building, implementing, or scaling your AI strategy in PV, there are 10 critical questions teams should ask when evaluating AI-enabled technology partners. From assessing controls and outsights to understanding how architecture can scale to support enterprise deployment over time, you will find these 10 questions (and much more) in our newest guide, the AI Integration Roadmap for Pharmacovigilance. Download it now to dive in: https://lnkd.in/gqDU7sGb , On October 1st, join industry peers and learn how dozens of leading life sciences organizations are moving beyond individual use cases in PV workflows toward a fully AI-powered PV operations model delivering tangible results. During this session, we’ll explore how NavaX AI-powered capabilities are already helping organizations: ✔️ Accelerate case intake with advanced AI delivering efficiency gains of 30% ✔️ Capture critical safety information while reducing manual effort with Dynamic Data Extraction, enabling faster case intake with 95% accuracy ✔️ Improve consistency and efficiency with AI Narrative Generation, achieving a 90% narrative similarity score ✔️ Optimize field case reporting with ReporterX and the latest NavaX Companion Agent, delivering 65% efficiency gains through advanced AI ✔️ Accelerate signal and risk management with Signal Agents, delivering context-aware insights and decision support in minutes rather than hours Secure your spot: https://lnkd.in/gzHAUu4Z (383 words, 2016-02-29) ## Listings & Categories - [Media Coverage Archives | ArisGlobal](/content/tag/media/index.html) (573 words) - [Media Coverage Archives | ArisGlobal](/content/category/media/media-coverage/index.html) (573 words) - [ArisGlobal Blogs Archives | ArisGlobal](/content/tag/arisglobal-blogs/index.html) (380 words) - [Breakthrough Archives | ArisGlobal](/content/category/blogs/breakthrough/index.html) (426 words) - [LifeSphere Safety Archives | ArisGlobal](/content/tag/lifesphere-safety/index.html) (334 words) - [Media Archives | ArisGlobal](/content/category/media/index.html) (473 words) - [Data and Analytics Archives | ArisGlobal](/content/tag/data-and-analytics/index.html) (152 words) - [blog Archives | ArisGlobal](/content/tag/blog/index.html) (343 words) - [Webinar Archives | ArisGlobal](/content/category/webinar/index.html) (364 words) - [data Archives | ArisGlobal](/content/tag/data/index.html) (164 words) - [LifeSphere Clarity Archives | ArisGlobal](/content/tag/lifesphere-clarity/index.html) (111 words) - [adverse event Archives | ArisGlobal](/content/tag/adverse-event/index.html) (150 words) - [clinical trial management system Archives | ArisGlobal](/content/tag/clinical-trial-management-system/index.html) (132 words) - [Clinical Trial Archives | ArisGlobal](/content/tag/clinical-trial/index.html) (229 words) - [Pharmacovigilance Archives | ArisGlobal](/content/tag/pharmacovigilance/index.html) (360 words) - [Clinical Archives | ArisGlobal](/content/tag/clinical/index.html) (301 words) - [Safety Signal Analytics Archives | ArisGlobal](/content/tag/safety-signal-analytics/index.html) (150 words) - [ArisGlobal Press Release Archives | ArisGlobal](/content/tag/arisglobal-press-release/index.html) (492 words) - [Clarity Archives | ArisGlobal](/content/tag/clarity/index.html) (111 words) - [EU CTR Archives | ArisGlobal](/content/tag/eu-ctr/index.html) (113 words) - [trial master file Archives | ArisGlobal](/content/tag/trial-master-file/index.html) (115 words) - [south korea Archives | ArisGlobal](/content/tag/south-korea/index.html) (115 words) - [automation Archives | ArisGlobal](/content/tag/automation/index.html) (112 words) - [Webinar Archives | ArisGlobal](/content/tag/webinar/index.html) (182 words) - [eregulatory summit Archives | ArisGlobal](/content/tag/eregulatory-summit/index.html) (131 words) - [medical information Archives | ArisGlobal](/content/tag/medical-information/index.html) (153 words) - [Connected Archives | ArisGlobal](/content/tag/connected/index.html) (114 words) - [Analytics Archives | ArisGlobal](/content/tag/analytics/index.html) (167 words) - [etmf Archives | ArisGlobal](/content/tag/etmf/index.html) (156 words) - [CRO Archives | ArisGlobal](/content/tag/cro/index.html) (113 words) - [CTMS Archives | ArisGlobal](/content/tag/ctms/index.html) (152 words) - [breakthrough Archives | ArisGlobal](/content/tag/breakthrough/index.html) (166 words) - [biopharma Archives | ArisGlobal](/content/tag/biopharma/index.html) (115 words) - [Event Archives | ArisGlobal](/content/category/events/index.html) (226 words) - [Press Release Archives | ArisGlobal](/content/tag/press-release/index.html) (323 words) - [Press Releases Archives | ArisGlobal](/content/category/media/press-release/index.html) (323 words) - [safety Archives | ArisGlobal](/content/tag/safety/index.html) (140 words) - [Xtalks Archives | ArisGlobal](/content/tag/xtalks/index.html) (117 words) - [Safety Signals Archives | ArisGlobal](/content/tag/safety-signals/index.html) (134 words) ## Products - [Advanced Signals Archives | ArisGlobal](/content/product/advanced-signals/index.html) (280 words) - [ABM Archives | ArisGlobal](/content/product/abm/index.html) (105 words) - [Sporify Archives | ArisGlobal](/content/product/sporify/index.html) (114 words) - [Reporter Archives | ArisGlobal](/content/product/reporter/index.html) (115 words) - [Intelligent Content Management Archives | ArisGlobal](/content/product/intelligent-content-management/index.html) (210 words) - [Medical Information Archives | ArisGlobal](/content/product/medical-information/index.html) (243 words) - [Signal and Risk Management Archives | ArisGlobal](/content/product/signal-and-risk-management/index.html) (145 words) - [Reporting and Analytics Archives | ArisGlobal](/content/product/reporting-and-analytics/index.html) (153 words) - [Advanced Intake Archives | ArisGlobal](/content/product/advanced-intake/index.html) (286 words) - [MultiVigilance Archives | ArisGlobal](/content/product/multivigilance/index.html) (163 words) ## Resources - [Full Page Index](/index.html): Browse all cached pages with rich metadata - [About This Cache](/about.html): Methodology, technical details, and usage guidelines - [XML Sitemap](/sitemap.xml): Machine-readable sitemap for crawler discovery - [Robots.txt](/robots.txt): Crawler directives - [Agentsite Network](https://agentsite.network/network.html): Public index of Agentsites and their machine-readable resources